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ABSTRACT

The present invention provides compositions and methods
for producing a transgenic plant that exhibits altered char
acteristics resulting from over expression or under expres
sion of a novel polypeptide PtM3 or its homolog PtM4. The
altered characteristics resulting from over-expression
include at least one of the ability to convert axillary meristem to floral meristem; to accelerate flowering i.e., early
flowering; to increase fruit production; to increase nut
production; to increase seed output; to increase branching; to
increase flower production; to increase fruit yield; to
increase flower yield and a combination thereof. The altered
characteristics resulting from suppressed expression include
at least one of complete sterility; partial sterility (sterility of
only one sex of a bisexual plant); reduced pollen production;
decreased flowering; increased biomass and combinations
thereof. Furthermore, once the transgenic plant is sterile,
additional exogenous sequences may be incorporated into
the sterile plant genome, resulting in other desired plant
characteristics. Related promoter, gene constructs, methods,
antibodies and kits are also provided.
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FIG. 1
PtM3 cONA sequence and corresponding amino acid sequence
1 AGAAGACAACCGAAGCACTTCTTTAAACTTATAACTTTCTCTTTCTACAAACATTTGTTG
61 TTCTCTCTATTATTGTTAAGGAATATGGGGAGAGGTAGAGTGGAGCTGAAGAGGATAGAG
M G R G R V E L K R I E

60
120

1 2 1 AACAAGATAAACAGGCAGGTGACATTTGCAAAGAGGAGAAATGGGTTGTTGAAGAAAGCT
N K I N R Q V T F A K R R N G L L K K A

180

1 8 1 TATGAGTTATCTGTGCTCTGTGATGCTGAGGTTGCTCTCATCATCTTCTCTAACCGTGGC
Y E L S V L C D A E V A L I
I F S N R G

240

2 4 1 AAGCTCTACGAGTTTTGTAGCACATCTAACATGCTGAAGACCCTGGAAAGGTATCAGAAG
K L Y E F C S T S N M L K T L E R Y Q K

300

301

TGCAGCTATGGTGCAGAAGAAGTCAATAAACCAGCCAAGGAGCTCGAGAACAGCTACAGG
C S Y G A E E V N K P A K E L E N S Y R

360

3 6 1 GAGTACTTGAAAGTGAAAGCAAGATTTGAGGGCCTACAACGAACTCAGAGGAACCTTCTT
E Y L K V K A R F E G L Q R T Q R N L L

420

4 2 1 GGAGAGGACCTCGGACCTCTGAATACCAAAGACCTTGAGCAGCTCGAGCGTCAGTTAGAG
G E D L G P L N T K D L E Q L E R Q L E

480

4 8 1 TCGTCATTGAACCAAGTTCGGTCAACTAAGACCCAGTATATGCTCGACCAACTTGCTGAT
S S L N Q V R S T K T Q Y M L D Q L A D

540

5 4 1 CTTCAAAATAAGGAACATCTGTTGCAGGAAGCTAACAGAGGTTTGACAATAAAGCTGGAT
L Q N K E H L L Q E A N R G L T I K L D

600

6 0 1 GAAATCAGTGCAAGAAATAGCCTCCGACCATCATGGGAAGGTGATGATCAGCAAAATATG
E I S A R N S L R P S W E G D D Q Q N M

660

6 6 1 TCCTACGGCCACCAGCATGCTCAGTCTCAGGGGCTATTCCAGGCTTTGGAATGCAATCCC
S Y G H Q H A Q S Q G L F Q A L E C N P

720

7 2 1 ACTTTGCAAATAGGCTACAACCCTGTTGGTTCAGACCAGGTGTCTGCAATAACACATGCC
T L Q I G Y W P V G S D Q V S A I T H A

780

7 8 1 ACCCAGCAAGTCCATGGGTTCATTCCAGGATGGATGCTTTGAGTTTTGTGCTCTTCATTG
T Q Q V H G F I
P G W M L *

840

8 4 1 CTCATAAAGGAGCACCTACCATGTAACTTTCTCTCTTGGTGTTGGTAATGTGTAAATGAT
9 0 1 TTCAAGAGCATGTGTACTTTCATTTGGACA

900
930
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FIG. 2
PtM4 cDNA sequence and corresponding amino acid sequence

1 GTGTGGTATATGGGGAGAGGTAGAGTGGAGCTGAAGAGGATAGAAAACAAAATTAATCGG 6 0
M G R G R V E L K R I E N K I N R
6 1 CAGGTGACATTTGCAAAGAGGAGAAATGGGTTGTTGAAGAAAGCTTATGAGTTATCTGTG 1 2 0
Q V T F A K R R N G L L K K A Y E L S V
1 2 1 CTCTGTGATGCTGAGGTTGCTCTCATCATCTTCTCTAACCGTGGCAAGCTCTACGAGTTT 1 8 0
L C D A E V A L I
I F S N R G K L Y E F
1 8 1 TGTAGCACATCTAACATGCTGAAGACCCTGGAAAGGTATCAGAAGTGCAGCTATGGTGCA 2 4 0
C S T S N M L K T L E R Y Q K C S Y G A
2 4 1 GAAGAAGTCAATAAACCAGCCAAGGAGCTCGAGAACAGCTACAGGGAGTACTTGAAAGTG 3 0 0
E E V N K P A K E L E N S Y R E Y L K V
3 0 1 AAAGCAAGATTTGAGGCCCTACAACGAACTCAGAGGAACCTTCTTGGAGAGGACCTCGGA 3 6 0
K A R F E A L Q R T Q R N L L G E D L G
361

CCTCTGAATACCAAAGATCTTGAGCAGCTCGAGCGTCAGTTAGAGTCGTCATTGAACCAA 4 2 0
P L N T K D L E Q L E R Q L E S
S L N Q

4 2 1 GTTCGGTCAACTAAGACCCAGTATATGCTCGACCAACTTGCTGATCTTCAAAATAAGGAA 4 8 0
V R S T K T Q Y M L D Q L A D L Q N K E
481

CATCTGTTGCTGGAAGCTAACAGAGGTTTGACAATAAAGCTGGATGAAATCAGTGCAAGA 5 4 0
H L L L ' E A N R G L T
I
K L D E
I
S A R

5 4 1 AATAGCCTCCGACCATCATGGGAAGGTGATGATCAGCAAAATATGTCCTACGGNCACCAG 6 0 0
N S L R P S W E G D D Q Q N M S Y G H Q
601

CACGCTCAGTCTCAGGGGCTATTCCAGGCTTTGGAATGCAATCCCACTTTGCAAATAGGC 6 6 0
H A Q S Q G L F Q A L E C N P T L Q I G

661

TACAACGCTGTTGGTTCAGACCAGGTGTCTGCAATAACACATGCCACCCAGCAAGTCCAT 7 2 0
Y N A V G S D Q V S A I T H A T Q Q V H

721

780

GGGTTCATTCCAGGATGGATGCTTTGAGTTTTGTGTTCTTCATTGCTCATAAAGGAGCAC
G F I P G W M L *
7 8 1 CTACCATGTAACTTTCTCTCTTGGTGTTGGTAATGTGTAAATGATTTCAAGAGCATGTGT
8 4 1 ACTTTCATTTGGACATGAAAACTTTATGTGGCTGGATTTCAGAACTTTAGCCAGGGACAC
9 0 1 GAGGCATGTAAAAG

840
900
914
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FIG. 3
ClustalW Alignment of predicted amino acid sequences of PtM3 and PtM4

PTM3
PTM4

PTM3
PTM4
PTM3
PTM4

MGRGRVELKRIENKINRQVTFAKRRNGLLKKAYELSVECDAEVALI IFSNRGKLYEFCSTSNMLXTLERYQKCSYGAEEVNKPfflKELENS
MGRGRVELKRIENKINRQVTFAKRRNGLLKKAYELSVgCDAEVALIIFSNRGKLYEFCSTSNMLKTLERYQKCSYGAEEVNKPgKELENS
y r e y l k v k a r f e a l q r t q r n l l g e d l g p l n t k H l e q l e r q J l e s s l n q v r s t k S q y m l d q l a d l q B k e h l l l e a n r g l t i KLDEISARNS

YREYLKVKARFEALQRTQRNLLGEDLGPLNTKflLBQLERQLLESSLNQVRSTKBQYMLDQLADLQSKEHLLLEANRGLTIKLDEISARNS
LRPSWEGDDQQNMSYGHQHAQSQGLFQALECNPTLQIGYNHVGSE)QVSAITHATQQVHGFIPGWMLl^^MM|M^^BB|^^B
lrpswegddqqnmsyghqhaqsqglfqalecnptlqigynIvgsdqvsaithatqqvhgfipgwivil^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H
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FIG. 4
Phylogenetic tree of predicted amino acid sequences of PtM3 (male dominant
expression) and PtM4 (female dominant expression) compared to various
floral and tree MADS-box sequences
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FIG. 5
PtM3 5’ untranslated region (UTR) containing PtM3 promoter and intron
sequence
2
62
122
182
242
302
362
422
482
542
602
662
722
782
842
902
962
1022
1082
1142

GGCCCGGCTGGTTCTCATGTTGGACTCCGACTTTAATTACTTTAACTACAAGCTTATTAT
AATTTTTTTTTTATACTATTTTATTTCATTTCAGTATTTAAACATTATTGTTTATATAAA
AAAATAGTTGAGCCCGTGGCAAAGCATAAACCAAGACCGAATATTCTAAATACTAAATTT
CTAGTTTGTTTGATTTCTCAATGCCCCGAACAGTAACGCTGTAATCAGACAACCTCATCC
GGACAAGCCAAATCAAGAACTTTCTCCAGTATCAAACCGACACGTGGAGGAGCTCCATTT
TAAGGGAGGGGACTACTTTCTGCCACGTGTGGAAACATCTGGAAATGACAAATTGATGCC
ATATAAAATTTTCTTACATGAAAGGACCACTGTCCCTTTTTACGCCCCACCGCAGCGCGT
GACCACACTTACAACCCTACCTCCAACAACACTGACACAATGACCGAGACGGTGGCGCGT
GAATACACTCTCCAAACTTAGAACCTACGTTCGTAATCAATGATGTGACAAAAAAGTAAA
AACCAAGAAGCTTTGAAAGCTAATAAATGAATTACTATATATATTATATCAATTCTTCAA
GAAAATTGGAAGAAATTATTTTTTTTCAATTTAATTTATAAATATAACTATTTAATGGGG
AAAGACTTCTATCCTTTGGAACCTTAATTGGAAAAGCAGCAACCCCATGCCGTTAACTTG
AAAAAAAACGAAACCCGGGTGTATTAAAAACTTACCAACAAGGGGGTAACCTTCCACTAA
CCGTGTACAATGGCAAAGTAACCCAACTTAAGGAAAAAGATTCCATAAATAAAACCATTT
TCAAAATGTAAAATATTTTTTCAAATATTTATAAATAACTATATTAATGTGAAAGCCATC
ATAATCCCGATTAGGAGATACTTAATTAGGAGAAAGTCAAGTCGAGAACCCCCATTGCCG
TTAATACTTGAAAAATAAACCAGTAAAATACACAGAGGTTGCATGTAACTAGAAAGAACA
GCTAACCCTAAGCTGCATTTCTTTTCTATATATATATATATATATAACAGAAAAGAAGAA
GACAACCGAAGCACTTCTTTAAACTTATAACTTTCTCTTTCTACAAACATTTGTTGTTCT
5 'U T R I n t r o n ->
CTCTATTATTGGTGGGTCTTTCTTTCTCTCTAGGGTTTCTTTAAAATATCTAACTTTCTC

1201

1202

TTCGTTTTTCACTTATTTTGTTACAGTTTGGGTTCTGATTCCTAAAAGTGTAGATCACCT

1261

1262

TCTTCTTGCTCTTGAGAGAAGAACAAGAAACGAAAAAAAAAACAAAAGAAAAGGAAAGAT

1321

1322

ATAAAGGAAATAAAGACTAATACAAAAGTAAATATATCATTAACTTACATGGTTAGATTT
5 ' UTR I n t r o n
ATGTATTAATTATAACGAAAGATGGTTTTTTATTTGGTTTTTTTTGGCTTGTGATTATAG

1381

1382

1 4 4 2 TTAAGGAATATGGGGAGAGGTAGAGTGGAGCTGAAGA
M G R G R V E L K

A
Start

codon fo r

PtM3
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FIG. 6
Flower specific mRNA expression of PtM3
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FIG. 7
Transgenic plants over-expressing PtM3
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FIG. 8
Transgenic plants containing antisense PtM3
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APPLICATION OF ASPEN MADS-BOX
GENES TO ALTER REPRODUCTION AND
DEVELOPMENT IN TREES

probes, MADS-box genes have been isolated from other
species including tomato (Mandel et al. Cell 71:133-143,
1992), tobacco (Kempin et al. Plant Physiol.
103:1041-1046, 1993), petunia (Angenent et al. Plant Cell
4:983-993, 1992), Brassica napus (Mandel et al. Cell
71:133-143, 1992), and maize (Schmidt et al. Plant Cell
5:729-737, 1993).
However, very few MADS-box genes have been cloned
from tree species. MADS-box genes were recently found in
spruce trees to encode transcription factors, which are key
components in the developmental control systems of coni
fers, such as the identity of the floral organs (Tandre, et al.
The Plant Journal 15(5), 615-623, 1998). Also, recently
another MADS-box gene, a DEFICIENS homolog and its
promoter were isolated from the dioecious tree, black cot
tonwood and were found to regulate expression in female
and male floral meristems of the two-whorled, unisexual
flowers (Strauss et al. Plant Physiology 124:627-639,
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SPONSORED RESEARCH OR DEVELOPMENT

5

This invention was made with government supported
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CROSS-REFERENCE TO RELATED
APPLICATIONS
Not Applicable.
15

TECHNICAL FIELD
The present invention relates to the production of geneti
cally altered plants having modified characteristics such as
conversion of axillary meristem to floral meristem; acceler
ated and earlier flowering; increased fruit production;
increased nut production; increased seed output; increased
branching; increased flower production; increased fruit
yield; increased flower yield and combinations thereof
obtained when the floral reproductive gene product PtM3 or
its homolog PtM4 are over-expressed in the plant reproduc
tive tissues. Furthermore, when the floral reproductive gene
product PtM3 or its homolog PtM4 are under-expressed in
a plant complete sterility; partial sterility; reduced pollen
production, decreased flowering, increased biomass and
combinations thereof can be obtained.
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BACKGROUND OF THE INVENTION
An enormous amount of effort has been expended in
attempts to elucidate the underlying mechanisms controlling
flower development in various dicotyledonous plant species
(reviewed in Coen, Annu. Rev. Plant Physiol. Plant Mol.
Biol. 42:241-279, 1991; and Gasser, Annu. Rev. Plant
Physiol. Plant Mol. Biol. 42:621-649, 1991), leading to the
isolation of a family of genes which encode certain regula
tory proteins. The most studied plant regulatory proteins
identified to date include AGAMOUS (AG) (Yanofsky et al.,
Nature 346:35-39, 1990), APETELAI (API) (Mandel et al.
Nature 360:273-277, 1992), and APETALA 3 (AP3) (Jack
et al. Cell 68:683-697, 1992) in Arabidopsis thaliana, and
DEFICIENS A (DEF A) (Sommer et al, EMBO J.
11:251-263, 1990), GLOBOSA (GLO) (Trobner et al,
EMBO J. 11:4693-4704, 1992), SQUAMOSA (SQUA)
(Huijser et al, EMBO J. 11:1239-1249, 1992), and PLENA
(PLE) (Bradley et al. Cell 72:85-95, 1993) in Antirrhinum
majus.
Sequence analysis of these plant regulatory genes has
revealed that their gene products contain a conserved
MADS-box region (Bradley et al. Cell 72:85-95, 1993;
Huijser et al, EMBO J. 11:1239-1249, 1992; Jack et al.
Cell 68:683-697, 1992; Mandel et al. Nature 360:273-277,
1992; Sommer et al, EMBO J. 11:251-263, 1990; Trobner
et al, EMBO J. 11:4693-4704, 1992; Yanofsky et al. Nature
346:35-39, 1990). Transgenic approaches have been
employed to study the functional roles of MADS-box genes
(Kempin et al. Plant Physiol. 103:1041-1046, 1993; Mandel et al. Cell 71:133-143, 1992). MADS-box genes have
been found to play an important role in specifying floral
meristems and floral oigan identity in plants such as Ara
bidopsis (Yanofsky et al. The Plant Cell, 7:721-733, 1995).
Furthermore, using conserved MADS-box regions as
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In addition, genetic engineering is slowly showing poten
tial for the improvement of qualitative and quantitative traits
in plants and trees. However, the full potential of transgenic
plants can not be realized until methods can be developed to
restrict or eliminate long distance migration of seeds and
pollen from transgenic plants. Accordingly, to facilitate the
production of genetically engineered trees, it is desirable that
the trees be completely reproductively sterile. The ability to
produce sterile transgenic trees is very desirable because
there is a high potential for escape of transgenes in trees into
wild populations due to their long distance movement of
seeds, pollen, and their ubiquitous wild relatives. Engineer
ing total male and female sterility for gene containment and
other desired traits or partial sterility for selective breeding
as discussed herein below is an important characteristic for
transgenic plants to possess. It would therefore be highly
desirable to have means to affect complete or partial repro
ductive sterility. The present invention satisfies this need and
provides related advantages as well.
Also, timing of the transition from vegetative growth to
flowering is one of the most important steps in plant devel
opment. This determines quality and quantity of most crop
species since the transition determines the balance between
vegetative and reproductive growth. It would therefore be
highly desirable to have means to affect the timing of this
transition so that flowering time can be controlled resulting
in earlier flowering and conversion of axillary meristems to
floral meristems.
Furthermore, traditionally, plant breeding involves gen
erating hybrids of existing plants, which are examined for
improved yield or quality. The improvement of existing
plant crops through plant breeding is central to increasing
the amount of food grown in the world since the amount of
land suitable for agriculture is limited. For example, the
development of new strains of crops, fruit and nuts through
plant breeding has increased the yield of these crops grown
in underdeveloped countries. Unfortunately, plant breeding
is inherently a slow process since plants must be reproduc
tively mature before selective breeding can proceed. For
some plant species, the length of time needed to mature to
flowering is so long that selective breeding, which requires
several rounds of backcrossing progeny plants with their
parents, is impractical. For example, some trees do not
flower for several years after planting. It would therefore be
highly desirable to have means to affect breeding of such
plant species for a variety of different economically valuable
or aesthetically pleasing traits.
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SUMMARY OF THE INVENTION

suppressing expression of the PtM3 protein or a functionally
equivalent fragment of the PtM3 protein sequence; express
ing a known cytotoxic gene product under the transcriptional
control of the PtM3 promoter or a functionally equivalent
fragment of the PtM3 promoter; and combinations thereof,
resulting in transgenic plants that may comprise either
complete sterility or partial sterility; wherein at least one of
the effects of the sterility is reduced pollen production;
decreased flowering; increased biomass and combinations
thereof; wherein the kit may include the following compo
nents: a purified antibody to at least one of PtM3 and PtM4
proteins or functionally equivalent fragments thereof, gene
constructs containing at least a promoter (i.e., either consti
tutive, tissue-specific, or temporal-specific) and a coding
region, containing the PtM3 polypeptide or a functionally
equivalent fragments thereof, host cells, and appropriate
controls.
The present invention provides kit for producing sterile
transgenic plants by suppressing the PtM3 promoter activity
or a functionally equivalent fragment of the PtM3 promoter;
suppressing expression of the PtM3 protein or a functionally
equivalent fragment of the PtM3 protein sequence; express
ing a known cytotoxic gene product under the transcriptional
control of the PtM3 promoter or a functionally equivalent
fragment of the PtM3 promoter; and combinations thereof,
wherein additional exogenous nucleotide sequences that
alter plant characteristics may be introduced in the genome
of the plant, wherein the altered plant characteristic includes
at least one of increased wood quality, increased growth,
increased pesticide resistance, increased herbicide resis
tance, and combinations thereof; wherein the kit may
include the following components: a purified antibody to at
least one of PtM3 and PtM4 proteins or functionally equiva
lent fragments thereof, gene constructs containing at least a
promoter (i.e., either constitutive, tissue-specific, or tempo
ral-specific) and a coding region, containing the PtM3
polypeptide or a functionally equivalent fragments thereof,
host cells, and appropriate controls.
The present invention also provides a method of growing
trangenically engineered plants in space. Plants grown extraterrestrially are insensitive to photoperiod and temperature
for flowering. Transgenic plants carrying the PtM3 gene
would be expected to flower in the extremely abnormal
growth conditions found in a space shuttle or space station.
The patents, references and articles cited herein are
hereby fully incorporated by reference. In the case of
conflict between the present disclosure and the incorporated
patents, references and articles, the present disclosure should
control.
The foregoing and other aspects of the invention will
become more apparent from the following detailed descrip
tion and accompanying drawings.

The present invention provides compositions and meth
ods for producing transgenic plants with altered character
istics by increasing the PtM3 promoter activity, or a func
tionally equivalent fragment of the PtM3 promoter,
increasing expression of the PtM3 protein, or a functionally
equivalent fragment of the PtM3 protein sequence, and
combinations thereof, the resulting transgenic plants com
prising at least one of the following plant characteristics
which include the ability to convert axillary meristem to
floral meristem; to produce accelerated flowering, i.e., ear
lier flowering, to increase fruit production; to increase nut
production; to increase seed output; to increase branching; to
increase flower production; to increase fruit yield; and to
increase flower yield.
The present invention also provides compositions and
methods for producing transgenic plants by suppressing the
PtM3 promoter activity or a functionally equivalent frag
ment of the PtM3 promoter; suppressing expression of the
PtM3 protein or a functionally equivalent fragment of the
PtM3 protein sequence; expressing a known cytotoxic gene
product under the transcriptional control of the PtM3 pro
moter or a functionally equivalent fragment of the PtM3
promoter; and combinations thereof, the resulting transgenic
plants comprising either complete sterility or partial sterility;
and wherein at least one of the effects of the sterility is
reduced pollen production; decreased flowering; increased
biomass and combinations thereof.
The present invention further provides compositions and
methods for producing sterile transgenic plants, by suppress
ing the PtM3 promoter activity or a functionally equivalent
fragment of the PtM3 promoter; suppressing expression of
the PtM3 protein or a functionally equivalent fragment of
the PtM3 protein sequence; expressing a known cytotoxic
gene product under the transcriptional control of the PtM3
promoter or a functionally equivalent fragment of the PtM3
promoter; and combinations thereof, wherein additional
exogenous nucleotide sequences that alter plant character
istics may be introduced into the genome of the plant, and
wherein the altered plant characteristic includes at least one
of increased wood quality, increased growth, increased
pesticide resistance, increased herbicide resistance, and
combinations thereof .
The present invention also provides kit for producing
transgenic plants by increasing the PtM3 promoter activity,
or a functionally equivalent fragment of the PtM3 promoter,
increasing expression of the PtM3 protein, or a functionally
equivalent fragment of the PtM3 protein sequence, and
combinations thereof, the resulting transgenic plants com
prising at least one of the following plant characteristics
which include the ability to convert axillary meristem to
floral meristem; to produce accelerated flowering, i.e., ear
lier flowering; to increase fruit production; to increase nut
production; to increase seed output; to increase branching; to
increase flower production; to increase fruit yield; and to
increase flower yield, wherein the kit may include the
following components: a purified antibody to at least one of
PtM3 and PtM4 proteins or functionally equivalent frag
ments thereof, gene constructs containing at least a promoter
(i.e., either constitutive, tissue-specific, or temporal-spe
cific) and a coding region, containing the PtM3 polypeptide
or a functionally equivalent fragments thereof, host cells,
and appropriate controls.
The present invention provides kit for producing trans
genic plants by suppressing the PtM3 promoter activity or a
functionally equivalent fragment of the PtM3 promoter;
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FIG. 1 illustrates the polynucleotide (SEQ ID NO:l)
sequence and amino acid (SEQ ID NO:4) sequence of Aspen
PtM3.
FIG. 2 illustrates the polynucleotide (SEQ ID NO:2)
sequence and amino acid (SEQ ID NO:5) sequence of Aspen
PtM4.
FIG. 3 illustrates the predicted amino acid sequence
alignment between Aspen PtM3 (SEQ ID NO: 4) and Aspen
PtM4 (SEQ ID NO: 5), wherein the sequence identity
between the two homologs is 97% using the Clustal W
sequence alignment algorithm. Clustal W is a general pur
pose multiple sequence alignment program for DNA or
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proteins. It produces biologically meaningful multiple
sequence alignments of divergent sequences. It calculates
the best match for the selected sequences, and lines them up
so that the identities, similarities and differences can be seen.
Details of algorithms, implementation and useful tips on
usage of Clustal programs can be found in the following
publications; Jeanmougin, F., Thompson, J. D., Gouy, M.,
Higgins, D. G. and Gibson, T. J. (1998) Multiple sequence
alignment with Clustal X. Trends Biochem Sci, 23, 403-5.
Thompson, J. D., Gibson, T. J., Plewniak, F., Jeanmiougin,
F. and Higgins, D. G. (1997) The Clustal X windows
interface: flexible strategies for multiple sequence alignment
aided by quality analysis tools. Nucleic Acids Research,
24:4876^1882. Higgins, D. G., Thompson, J. D. and Gibson,
T. J. (1996) Using CLUSTAL for multiple sequence align
ments. Methods Enzymol., 266, 383^102.
FIG. 4 illustrates the phylogenetic tree of predicted amino
acid sequences of PtMl, PtM2, PtM3 (male dominant
expression) and PtM4 (female dominant expression) com
pared to various floral and tree MADS-box sequences. The
phylogenetic tree including several MADS-box genes is
shown in FIG. 4, indicating that PtM3 and PtM4 occupy a
separate branch and are not identical to Arabidopsis AGL
(Sepallata) genes. The phylogenetic analysis was obtained
by heuristic search algorithms using the PAUP (Phyloge
netic Analysis Using Parsimony) version 4.0 beta 4a soft
ware tool for comparative biological sequence analysis.
Starting with a set of aligned sequences, a search was
performed for phylogenetic trees that were optimal (standard
default parameters may be applied). Heuristic search analy
sis was done on sequence alignments followed by Bootstrap
analysis using 100 replicates. Branch numbers refer to the
number of replicates that support the branch. Accession
numbers of sequences and names of plant species are
provided immediately below:
[Populus tremuloides] PTM1; PTM2; PtM3; PtM4: [Populus
balsamifera
subsp.
trichocarpa\
PtAG2,
AAC06238.1; PtAGl, AAC06237.1; PtD, AAC13695.2;
[Antirrhinum majus] DEFA, S12378; GLO, Q03416;
SQUA, S20886; DEFH125, T17029; DEFH72, S71756;
DEFH49, S78015; [Arabidopsis thaliana] AG, P17839;
AGL1/SHP1, CAB88295; AGL2/SEP1, T51409; AGL3,
S57793; AGL4/SEP2, D39534; AGL5, E39534; AGL6,
F39534; AGL8, S71208; AGL9/SEP3, T00656; AGL11,
T04000; AGL12, AAF23331; AGL13, T47904; AGL14,
T09347; AGL15, S71200; AGL17, T05621; AGL18,
AAG37900; AGL 19, AAG37901; AGL20, AAG16297;
AGL24, T05580; AGL27-I, AAG37902; AGL27-II,
AAG37903; AGL29, T02331; AGL31, AAG37904; API/
AGL7, P35631; AP3, A42095; PI, A53839; [Brassica
napus] AGL15-1, T07867; AGL15-2, T07869; [Eucalyp
tus grandis] EGM1, AAC78282; EGM2, AAC78283;
EGM3, AAC78284; EAP2L, AAG30923; EAP2S,
AAG27459; EAP1, AAG24909; [Malus domestical]
MDM1, AAC25922; MDM2, AAC83170; MDM3,
AAD51422; MDM4, AAD51423; MDM5, CAA04321;
MDM6, CAA04322; MDM7, CAA04324; MDM8,
CAA04919; MDM9, CAA04920; MDM10, CAA04324;
[Petunia hybrida] PAG, Q40885; FBP1, JQ1689; FBP2,
JQ1690; TM6, AAF73933: [Nicotiana tabacum] NtDEF,
CAA65288; NtGLO, Q03416; NtMl, S46526; NtM4,
AAF76381; NtM5, AAD39035; NtAGl, Q43585; [Lycopersicon esculentum] TAG1, T07185; TDR3, S23729;
TDR5, CAA43170; TDR6, S23731.
FIG. 5 illustrates the polynucleotide sequence of the PtM3
Promoter (SEQ ID NO: 3) along with the 5'-untranslated
region (UTR) and intron sequence. The PtM3 promoter (See

bolded sequence from 1153 to 1441) contains a MADS-box
sequence motif, which is believed to regulate gene expres
sion by binding to sites, known as CArG boxes, TATA
sequences, etc., present in the promoter regions of plant
MADS-box genes (Riechmann et ah, Biol. Chem. 378:
1079-1101 (1998).
FIG. 6 illustrates the flower specific mRNA expression of
PtM3 and PtM4. RNA (10 pg) from each developmental
stage of female aspen flowers was fractionated on a 1.2%
formaldehyde agarose gel and transferred to Hybond™
N-nylon membranes (purchased from Amersham). The blot
was hybridized to 32P-labeled probe at 68° C. and washed at
high stringency. The specific 3'UTR of PtM3 was used as a
probe. Panel A shows expression of PtM3 mRNA at specific
flower bud developmental stages, as compared to control
tissues (leaf and xylem RNA). Panel B shows expression of
PtM4 mRNA at specific flower bud developmental stages, as
compared to control tissues (leaf and xylem RNA). Panel C
shows the differential expression of male PtM3 (M) and
female (F) PtM4 floral buds from stage 4 as compared to leaf
(L) and xylem (X) RNA. Panel D shows the result of having
the 3'-UTR probe of PtM3 used to hybridize against total
RNA from Stage 4 male and female buds.
FIG. 7 illustrates the various phenotypes of transgenic
plants over-expressing PtM3. Panel A, shows a tobacco
plant from transgenic line PtM3-21 (right) displaying early
flowering and conversion of axillary meristems to floral
meristems as compared to a WT tobacco plant (left). Panel
B, shows a T1 generation plant from one control construct
from line pTCS5. Panel C, shows a T1 generation plant from
transgenic line PtM3-9-9. Panel D, shows a T3 generation
transgenic Arabidopsis from line PtM3-4-3 (right) display
ing increased branching and flower pod production as com
pared to WT (left). Panel E, shows a graph depicting the
average seed yields (mg) in the transgenic PtM3-4-3 plants
(right) as compared to WT (left).
FIG. 8 illustrates transgenic plants containing antisense
PtM3. In panel A, the control is flowering. In panel B, the
antisense PtM3 tobacco plant is not flowering; in fact, the
antisense PtM3 transgenic plants mature and begin senescing and eventually die without flowering. Panel C shows a
transgenic tobacco plant containing inverted repeats of part
of the PtM3 sequence which does not form flowers, in
comparison to the control plants that form normal flowers
(panel D). Panels E and F show the absence of petals and
stamens when an inverted repeat of male PtM3 is introduced
into the bisexual tobacco plant. Only female sex organs are
formed and may be pollinated by pollen from a control to
form pods. This shows that the PtM3 may also have a role
in the male sex determination. Panel G shows flowerless
Arabidopsis terminal and Panel H shows normal pod devel
opment in the control plant.
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DETAILED DESCRIPTION OF THE
INVENTION
The present invention provides compositions, methods,
and kits for producing transgenic plants with a number of
desirable plant characteristics. Before one can appreciate the
altered plant characteristics provided herein, more detailed
knowledge of the invention may be desired and follows.
A flower, like a leaf or shoot, is derived from the shoot
apical meristem, which is a collection of undifferentiated
cells set aside during embryogenesis. The production of
vegetative structures, such as leaves or shoots, and of
reproductive structures, such as flowers, is temporally seg
regated, such that a leaf or shoot arises early in a plant life
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cycle, while a flower develops later. The transition from
vegetative to reproductive development is the consequence
of a process termed floral induction (Yanofsky, Ann. Rev.
Plant Physiol. Plant Mol. Biol. 46:167-188 (1995), which is
incorporated herein by reference).
Once induced, shoot apical meristem either persists and
produces floral meristem, which gives rise to flowers, and
lateral meristem, which gives rise to branches, or is itself
converted to floral meristem. Floral meristem differentiates
into a single flower having a fixed number of floral organs
in a whorled arrangement. Dicots, for example, contain four
whorls (concentric rings), in which sepals (first whorl) and
petals (second whorl) surround stamens (third whorl) and
carpels (fourth whorl).
Although shoot meristem and floral meristem both consist
of meristemic tissue, shoot meristem is distinguishable from
the more specialized floral meristem. Shoot meristem gen
erally is indeterminate and gives rise to an unspecified
number of floral and lateral meristems. In contrast, floral
meristem is determinate and gives rise to the fixed number
of floral organs that comprise a flower.
Genetic studies have identified a number of genes
involved in regulating flower development. These genes can
be classified into different groups depending on their func
tion. Flowering time genes, for example, are involved in
floral induction and regulate the transition from vegetative to
reproductive growth. In comparison, the floral meristem
identity genes, which are the subject matter of the present
invention as disclosed herein, encode proteins that promote
the conversion of shoot meristem to floral meristem in an
angiosperm. In addition, floral organ identity genes encode
proteins that determine whether sepals, petals, stamens or
carpels are formed during floral development (Yanofsky,
supra, 1995; Weigel, Ann. Rev. Genetics 29:19-39 (1995),
which is incorporated herein by reference). Some of the
floral meristem identity gene products also have a role in
specifying floral oigan identity.
Many floral identity genes may be characterized as plant
MADS box genes. The plant MADS box genes generally
encode proteins of about 260 amino acids including a highly
conserved MADS domain of about 56 amino acids (Riechmann and Meyerowitz, Biol. Chem. 378:1079-1101 (1997),
which is incorporated herein by reference). The MADS
domain, which was first identified in the Arabidopsis AGAMOUS and Antirrhimum majus DEFICIENS genes, is con
served among transcription factors found in humans (serum
response factor; SRF) and yeast (MCM1; Norman et ah, Cell
55:989-1003 (1988); Passmore et al., J. Mol. Biol. 204:
593-606 (1988), and is the most highly conserved region of
the MADS domain proteins. The MADS domain is the
major determinant of sequence specific DNA-binding activ
ity and can also perform dimerization and other accessory
functions (Huang et al., The Plant Cell 8:81-94 (1996)). The
MADS domain frequently resides at the N-terminus,
although some proteins contain additional residues at the
N-terminus to the MADS domain.
The “intervening domain” or “I-domain,” located imme
diately at the C-terminus to the MADS domain, is a weakly
conserved domain having a variable length of approximately
30 amino acids (Purugganan et al., Genetics 140:345-356
(1995)). In some proteins, the I-domain plays a role in the
formation of DNA-binding dimers. A third domain present
in plant MADS domain proteins is a moderately conserved
70 amino acid region denoted the “keratin-like domain” or
“K-domain.” Named for its similarity to regions of the
keratin molecule, the structure of the K-domain appears
capable of forming amphipathic helices and may mediate

protein-protein interactions (Ma et al., Genes Devel.
5:484-495 (1991)). The most variable domain, both in
sequence and in length, is the carboxy-terminal or “C-domain” of the MADS domain proteins. Dispensable for DNA
binding and protein dimerization in some MADS domain
proteins, the function of this C-domain remains unknown.
The term “ectopically expressible” is used herein to refer
to a nucleic acid molecule encoding a floral reproductive
gene product that can be expressed in a tissue other than a
tissue in which it normally is expressed or at a time other
than the time at which it normally is expressed, provided that
the floral reproductive gene product is not expressed from its
native, naturally occurring promoter. Ectopic expression of
a floral reproductive gene product is a result of the expres
sion of the gene coding region from a heterologous promoter
or from a modified variant of its own promoter, such that
expression of the floral reproductive gene product is no
longer in the tissue in which it normally is expressed or at
the time at which it normally is expressed. An exogenous
nucleic acid molecule encoding a PtM3 or PtM4 gene
product under the control of its native, wild type promoter,
for example, does not constitute an ectopically expressible
nucleic acid molecule encoding a floral reproductive gene
product. However, a nucleic acid molecule encoding an
PtM3 or PtM4 gene product under the control of a consti
tutive promoter, which results in expression of PtM3 or
PtM4 in a tissue such as shoot meristem where it is not
normally expressed, is an ectopically expressible nucleic
acid molecule as defined herein.
Actual ectopic expression of a floral reproductive gene is
dependent on various factors and can be constitutive, tissuespecific, temporal specific or inducible expression. For
example, PtM3 or PtM4, which normally may be expressed
in floral meristem, may be ectopically expressible in the
terminal axillary meristem of a plant, such as an angiosperm.
As disclosed herein, when a floral reproductive gene product
such as PtM3 or PtM4 is ectopically expressed in floral
meristem of a plant, such as in an angiosperm, the axillary
meristem is converted to floral meristem and early repro
ductive development occurs.
As disclosed herein, an ectopically expressible nucleic
acid molecule encoding a floral reproductive gene product
can be, for example, a transgene encoding a floral repro
ductive gene product under the control of a heterologous
gene regulatory element. In addition, such an ectopically
expressible nucleic acid molecule may be an endogenous
floral reproductive gene coding sequence that is placed
under the control of a heterologous gene regulatory element.
The ectopically expressible nucleic acid molecule also may
be, for example, an endogenous floral reproductive gene
having a modified gene regulatory element such that the
endogenous floral reproductive gene is no longer subject to
negative regulation by a transcription factor.
Also, an ectopically expressible nucleic acid molecule
encoding a floral reproductive gene product can be
expressed, as desired, either constitutively or inducibly.
Such an ectopically expressible nucleic acid molecule
encoding a floral reproductive gene product can be an
endogenous floral reproductive gene that has, for example,
a mutation in a gene regulatory element. An ectopically
expressible nucleic acid molecule encoding a floral repro
ductive gene product also can be an endogenous nucleic acid
molecule encoding a floral reproductive gene product that is
linked to an exogenous, heterologous gene regulatory ele
ment that confers ectopic expression. In addition, an ectopi
cally expressible nucleic acid molecule encoding a floral
reproductive gene product can be an exogenous nucleic acid
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molecule that encodes a floral reproductive gene product
under control of a heterologous gene regulatory element.
As used herein, the term “transgenic” refers to a plant or
a tree that contains in its genome an exogenous nucleic acid
molecule, which can be derived from the same or a different
plant species. The exogenous nucleic acid molecule can be
a gene regulatory element such as a promoter, enhancer or
other regulatory element or can contain a coding sequence,
which can be linked to a heterologous gene regulatory
element.
The term “tree” encompasses any tree and progeny
thereof. The term also encompasses parts of trees, including
seed, cuttings, tubers, fruit, flowers, etc. A list of non
limiting examples of trees to which the invention may apply
include hardwood trees such as Populus species, cotton
woods, Sweetgum, or eucalyptus and fruit trees such as
apple, peach, nut trees such as walnuts, pecans or almonds.
The term “plant” encompasses any plant and progeny
thereof. The term also encompasses parts of plants, includ
ing seed, cuttings, tubers, fruit, flowers, etc. The term
“plant” also includes whole plants and portions of plants,
including plant organs (e.g., roots, stems, leaves, etc). A list
of non-limiting examples of plants to which the invention
may apply include herbaceous plants (e.g., Arabidopsis,
asparagus and tobacco) and crop plants (e.g., Common bean
(.Phaseolus vulgaris), Maize or corn (Zea mays), Pea (Pisum
sativum), Squashes (Cucurbita spp.), Potato (Solarium spp.),
Tomato (Lycopersicon esculentum), Groundnut or peanut
(.Arachis hypogaea), Wheat (Triticum spp.), Barley (Plordeum vulgare), Sunflower (,Helianthus annuus), Peppers
(iCapsicum annuum), Sorghum (Sorghum bicolor), Rice
(Oryza sativa), Banana & plantain (Musa spp. ), Cotton
(Gossypium spp.), Cabbages, turnips, etc. (Brassica spp.),
Soybean (Glycine max), Lentil (Lens culinaris) Alfalfa
(.Medicago sativa), Field bean (Vicia faba), Cowpea (Cigna
unguiculata), Coconut (Cocos nucifera), Lettuce (Lactuca
sativa), Walnut (Juglans spp.), Melon and cucumber (Cucumis spp.) Almonds and peaches (Prunus spp.), Olive (Olea
europea), Grape (Vitis spp.), Citrus (Citrus spp.), Cassava
(Manihot esculentum), Sugarcane (Saccharum spp.), Pigeon
pea (Cajanus cajan), Chickpea or garbanzo (Cicer arietinum), Oat (Avena sativa spp.), Flax (Linum usitatissimum),
and Coffee (Coffea arabica).
As used herein, the term “floral gene product” means a
gene product (i.e., a polypeptide) that, for example, pro
motes conversion of axillary meristem to floral meristem in
a plant e.g., an angiosperm, such as PtM3, homologs,
orthologs or functionally equivalent fragments thereof. As
disclosed herein in Example 5, expression of a floral repro
ductive gene product such as PtM3 can convert axillary
meristem to floral meristem, promote early reproductive
development, increase branching, increase flower pod pro
duction, and increase seed yields in an angiosperm.
Floral genes in particular are conserved among distantly
related angiosperm and gymnosperm species. The conser
vation of floral gene products in non-flowering plants such
as coniferous trees indicates that floral meristem genes can
promote the reproductive development of gymnosperms as
well as angiosperms.
As used herein, the term “seed plant” means an
angiosperm or gymnosperm. An angiosperm is a seed
bearing plant whose seeds are borne in a mature ovary
(fruit). Angiosperms are divided into two broad classes
based on the number of cotyledons, which are seed leaves
that generally store or absorb food. Thus, a monocotyledonous angiosperm is an angiosperm having a single cotyledon,
and a dicotyledonous angiosperm is an angiosperm having

two cotyledons. Angiosperms are well known and produce
a variety of useful products including materials such as
lumber, rubber, and paper; fibers such as cotton and linen;
herbs and medicines such as quinine and vinblastine; orna
mental flowers such as roses and orchids; and foodstuffs
such as grains, oils, fruits and vegetables.
Angiosperms encompass a variety of flowering plants,
including, for example, cereal plants, herbaceous plants
(such as for example tobacco plants or Arabidopsis plants,
etc.), crop plants, perennial plants, seed plants, leguminous
plants, oilseed plants, hardwood trees, fruit-bearing plants,
and ornamental flowers, which general classes are not nec
essarily exclusive. Cereal plants, which produce an edible
grain cereal, include, for example, com, rice, wheat, barley,
oat, rye, orchardgrass, guinea grass, sorghum and turfgrass.
In addition, a leguminous plant is an angiosperm that is a
member of the pea family (Fabaceae) and produces a char
acteristic fmit known as a legume. Examples of leguminous
plants include, for example, soybean, pea, chickpea, moth
bean, broad bean, kidney bean, lima bean, lentil, cowpea,
dry bean, and peanut. Examples of legumes also include
alfalfa, birdsfoot trefoil, clover and sainfoin. An oilseed
plant also is an angiosperm with seeds that are useful as a
source of oil. Examples of oilseed plants include soybean,
sunflower, rapeseed and cottonseed. The skilled artisan will
recognize that the methods of the invention can be practiced
using these or other angiosperms, as desired.
An angiosperm also can be a hardwood tree, which is a
perennial woody plant that generally has a single stem
(trunk). Examples of such trees include alder, ash, aspen,
basswood (linden), beech, birch, cherry, cottonwood, elm,
eucalyptus, hickory, locust, maple, oak, persimmon, poplar,
sweetgum, sycamore, pecans, almonds, walnut and willow.
Other trees that are encompassed by this invention are
dioecious trees (sexes are on different trees), hybrid trees,
bisexual trees (both female and male sexes are located on
one tree), and pollen producing trees. Trees are useful, for
example, as a source of pulp, paper, structural material, fuel
and for maintaining biodiverse forestry in an urban setting
(i.e., urban forestry).
An angiosperm also can be a fruit-bearing plant, which
produces a mature, ripened ovary (usually containing seeds)
that is suitable for human or animal consumption. For
example, hops used for their flavoring in malt liquor are a
member of the mulberry family. Fruit-bearing angiosperms
also include grape, orange, lemon, grapefruit, avocado, date,
peach, cherry, olive, plum, coconut, apple and pear trees and
blackberry, blueberry, raspberry, strawberry, pineapple,
tomato, cucumber and eggplant plants. An ornamental
flower is an angiosperm cultivated for its decorative flower.
Examples of commercially important ornamental flowers
include rose, orchid, lily, tulip and chrysanthemum, snap
dragon, camellia, carnation and petunia plants. The skilled
artisan will recognize that the methods of the invention can
be practiced using these, other angiosperms, or hybrid plants
or hybrid trees thereof, as desired.
The term “gymnosperm” refers to plants that produce
naked seeds, i.e., seeds that are not encased in an ovary. A
specific example of a gymnosperm is Pinus taeda (L.)
[loblolly pine]. Gymnosperms encompass four classes:
cycads, ginkgo, conifers and gnetophytes. The conifers are
the most widespread of living gymnosperms and frequently
are cultivated for structural wood or for pulp or paper.
Conifers include redwood trees, pines, firs, spruces, hem
locks, Douglas firs, cypresses, junipers and yews. The
skilled artisan will recognize that the methods of the inven
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tion can be practiced with these, other gymnosperms, or
hybrid plants or hybrid trees thereof, as desired.
The term “dioecious tree” refers to trees having male
reproductive oigans in one tree and female in another (i.e.,
the female and male reproductive organs are on different
trees). Also, the staminate and the pistillate flowers are borne
on different trees.
As used herein, the term “introducing,” when used in
reference to a nucleic acid molecule and a seed plant such as
an angiosperm or a gymnosperm, means transferring an
exogenous nucleic acid molecule into the seed plant. For
example, an exogenous nucleic acid molecule encoding a
floral reproductive gene product can be introduced into a
seed plant by a variety of methods including Agrobacteriummediated transformation or direct gene transfer methods
such as electroporation or microprojectile-mediated trans
formation.
The term “transformation” refers to the transfer of a
foreign gene into the genome of a host organism and its
genetically stable inheritance.
Transformation methods based upon the soil bacterium
Agrobacterium tumefaciens, known as “agro-infection,” are
useful for introducing a nucleic acid molecule into a broad
range of angiosperms and gymnosperms. The wild type form
of Agrobacterium contains a Ti (tumor-inducing) plasmid
that directs production of tumorigenic crown gall growth on
host plants. Transfer of the tumor-inducing T-DNA region of
the Ti plasmid to a plant genome requires the Ti plasmidencoded virulence genes as well as T-DNA borders, which
are a set of direct DNA repeats that delineate the region to
be transferred. Agrobacterium-based vector is a modified
form of a Ti plasmid, in which the tumor-inducing functions
are replaced by nucleic acid sequence of interest to be
introduced into the plant host.
Current protocols for Agrobacterium-mediated transfor
mation employ cointegrate vectors or, suitably, binary vector
systems in which the components of the Ti plasmid are
divided between a helper vector, which resides permanently
in the Agrobacterium host and carries the virulence genes,
and a shuttle vector, which contains the gene of interest
bounded by T-DNA sequences. A variety of binary vectors
are well known in the art and are commercially available
from, for example, Clontech (Palo Alto, Calif.). Methods of
coculturing Agrobacterium with cultured plant cells or
wounded tissue such as leaf tissue, root explants, hypocotyledons, stem pieces or tubers, for example, also are well
known in the art (Click and Thompson (eds.), Methods in
Plant Molecular Biology and Biotechnology, Boca Raton,
Fla.: CRC Press (1993), which is incorporated herein by
reference). Wounded cells within the plant tissue that have
been infected by Agrobacterium can develop oigans de novo
when cultured under the appropriate conditions; the result
ing transgenic shoots eventually give rise to transgenic
plants containing the exogenous nucleic acid molecule of
interest.
Agrobacterium-mediated transformation has been used to
produce a variety of transgenic seed plants (see, e.g., Wang
et al. (eds), Transformation of Plants and Soil Microorgan
isms, Cambridge, UK: University Press (1995), which is
incorporated herein by reference). For example, Agrobacte
rium-mediated transformation can be used to produce trans
genic crudiferous plants such as Arabidopsis, mustard, rapeseed and flax; transgenic leguminous plants such as alfalfa,
pea, soybean, trefoil and white clover; and transgenic
solanaceous plants such as eggplant, petunia, potato,
tobacco and tomato. In addition, Agrobacterium-mediated
transformation can be used to introduce exogenous nucleic

acids into apple, aspen, belladonna, black currant, carrot,
celery, cotton, cucumber, grape, horseradish, lettuce, morn
ing glory, muskmelon, neem, poplar, strawberry, sugar beet,
sunflower, walnut and asparagus plants (see, for example,
Glick and Thompson, supra, 1993). Furthermore, methods
for generating transgenic plants such as Aspen are known to
those skilled in the art and can be readily found in the
following references: Boeijan W, Baucher M, Chabbert B,
Petit-Conil M, Leple J C, Pilate G, Cornu D, Monties B, Inze
D, Van Doorsselaere J, Jouanin L and Van Monatgu M, with
Tsai C-J, Podila G K and Chiang V L (1997) Genetic
modification of lignin biosynthesis in quaking aspen and
poplar. In: Klopfenstein NB, Chun Y W, Kim M S, Ahuja M
R, eds Dillon, M C, Carman R C, Eskew L G, tech eds.
Micropropagation, genetic engineering and molecular biol
ogy of Populus. Gen. Tech. Rep RM-GTR-297. Fort Collins,
Colo.: USDA, Forest Service, Rocky Mountain research
station, pp 193-205; Kamosky, D. F., B. Sen, J. Kim, B.
Xiang, X. Lu, L. Cseke, D. Dixon, J. J. Liu, G. Wyckofif, and
Gopi K. Podila. 2000; Engineering reproductive sterility in
forest trees. Proc. International Workshop BIO-REFOR.
Nepal, 1999. pp. 7-11; Genetic engineering of Populus
species to improve resistance to environmental stresses;
Tsai, C. J., Podila, G. K. and Chiang, V. L., (1994) Agro
bacterium-mediated transformation of quaking aspen
(Populus tremuloides) and regeneration of transgenic plants.
Plant Mol. Biol. 14: 94-97; Tsai C J, Popko J L, Mielke M
R, Flu W J, Podila G K, Chiang V L. 1998. Suppression of
O-methyltransferase gene by homologous sense transgene in
quaking aspen causes red-brown wood phenotypes. Plant
Physiol. 117: 101-12.
Microprojectile-mediated transformation also is a well
known method of introducing an exogenous nucleic acid
molecule into a variety of seed plant species. This method,
first described by Klein et al., Nature 327:70-73 (1987),
which is incorporated herein by reference, relies on micro
projectiles such as gold or tungsten that are coated with the
desired nucleic acid molecule by precipitation with calcium
chloride, spermidine or PEG. The microprojectile particles
are accelerated at high speed into seed plant tissue using a
device such as the Biolistic™ PD-1000 (Biorad, Flercules,
Calif.).
Microprojectile-mediated delivery or “particle bombard
ment” is especially useful to transform seed plants that are
difiScult to transform or regenerate using other methods.
Microprojectile-mediated transformation has been used, for
example, to generate a variety of transgenic seed plant
species, including cotton, tobacco, com, hybrid poplar and
papaya (see, for example, Glick and Thompson, supra,
1993). The transformation of important cereal crops such as
wheat, oat, barley, sorghum and rice also has been achieved
using microprojectile-mediated delivery (Duan et al., Nature
Biotech. 14:494-498 (1996); Shimamoto, Curr. Opin. Bio
tech. 5:158-162 (1994), each of which is incorporated
herein by reference). A rapid transformation regeneration
system for the production of transgenic plants, such as
transgenic wheat, in two to three months also can be useful
in producing a transgenic seed plant of the invention (Euro
pean Patent No. EP 0 709 462 A2, Application number
95870117.9, filed Oct. 25, 1995, which is incorporated
herein by reference). In addition to the methods for plant
transformation and regeneration described above for making
transgenic plants, other well-known methods can be
employed.
Methods of transforming forest trees including both
angiosperms and gymnosperms also are well known in the
art. Transgenic angiosperms such as members of the genus
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Populus, which includes aspens and poplars, have been
generated using Agrobacterium-mediated transformation,
for example. In addition, transgenic Populus and sweetgum,
are of interest for biomass production and for fuel produc
tion. Transgenic gymnosperms, including conifers such as
white spruce and larch, also have been obtained, for
example, using microprojectile bombardment (Wang et ah,
supra, 1995). The skilled artisan will recognize that Agro
bacterium-mediated transformation such as Boerjan et ah,
1997; Kamosky et al., 2000; Kim, J. H. 1998; Tsai et al,
1994 and 1998; can be a very suitable method of introducing
a nucleic acid molecule encoding a floral reproductive gene
product into a seed plant according to the methods of the
invention.
The term “converting axillary meristem to floral meristem,” as used herein, means promoting the formation of
flower progenitor tissue where axillary progenitor tissue
otherwise would be formed in the angiosperm and gyrnnosperm. As a result of the conversion of axillary meristem to
floral meristem, flowers form in an angiosperm or gyrnnosperm where axillary meristems normally would form. The
conversion of axillary meristem to floral meristem can be
identified using well known methods, such as scanning
electron microscopy, light microscopy or visual inspection
(see, for example, Mandel and Yanofsky, Plant Cell
7:1763-1771 (1995), which is incorporated herein by ref
erence).
A “promoter” is a polynucleotide containing element such
as a TATA box, which is capable of binding RNA poly
merase in a cell and initiating transcription of a downstream
(3' direction) coding sequence. For purposes of defining the
present invention, the promoter sequence is bounded at its 3'
terminus by the transcription initiation site and extends
upstream (5' direction) to include the minimum number of
bases or elements necessary to initiate transcription at levels
detectable above background. Within the promoter sequence
will be found a transcription initiation site (conveniently
defined, for example, by mapping with nuclease SI), as well
as protein binding domains (consensus sequences) respon
sible for the binding of RNA polymerase. Examples of
promoters that can be used in the present invention include
constitutive, tissue and temporal specific promoters.
A variety of plant gene promoters that are regulated in
response to environmental, hormonal, chemical, and/or
developmental signals, also can be used for expression of the
floral reproductive genes in plant cells, including promoters
regulated by: (a) heat (Ainley et al. (1993). Regulatable
endogenous production of cytokinins up to “toxic” levels in
transgenic plants and plant tissues. Plant Mol. Biol.
22:13-23.); (b) light (e.g., the pea rbcS-3Apromoter (Kuhlemeier et al. (1989). Plant Cell 1:471.) and the maize rbcS
promoter (SchafiSer and Sheen (1991). Plant Cell 3:997.), (c)
hormones, such as abscisic acid (Marcotte et al. (1989).
Plant Cell 1:969.), (d) wounding (Siebertz et al. (1989.),
Plant Cell 1:961.), and (e) chemicals such as methyl jasminate or salicylic acid (Gatz (1997). Chemical control of gene
expression. Ann. Rev. Plant Physiol. Plant Mol. Biol.
48:89-108.) can also be used to regulate gene expression.
Alternatively, tissue specific promoters (i.e., root, leaf,
flower, and seed for example) can be fused to the coding
sequence to obtain particular expression in respective
organs. (Denis et al. (1993). Expression of engineered
nuclear male sterility in Brassica napus. Plant Physiol. 101:
1295-1304.) In addition, the timing of the protein expres
sion can be controlled by using promoters such as those
acting at senescencing (See, Gan and Amasino (1995),
inhibition of leaf senescence by autoregulated production of

cytokinin. Science 270:1986-1988.) or during late seed
development (See, Odell et al. (1994). Seed specific gene
activation mediated by the Cre/lox site-specific recombina
tion system. Plant Physiol. 106:447-458). Therefore, there
are a variety of different types of promoters that may be used
in this invention.
The term “tissue-specific promoter” refers to a promoter
which directs the expression of a gene into a specific tissue
such as reproductive tissues.
The term “temporal-specific promoter” refers to a pro
moter which temporally directs the expression of a gene so
that the gene expression in the plant can be regulated based
on time i.e., seasonally.
Furthermore, an appropriate regulatory element such as a
promoter may be selected depending on the desired pattern
or level of expression of a nucleic acid molecule linked
thereto. For example, a constitutive promoter, which is
active in all tissues, would be appropriate if expression of a
gene product in all plant tissues is desired. In addition, a
developmentally regulated or tissue-specific or temporalspecific regulatory element can be useful to direct floral
reproductive gene expression to specific tissues, for
example. As discussed above, inducible expression also can
be particularly useful to manipulate the timing of gene
expression such that, for example, a population of transgenic
plants, such as seed plants of the invention that contain an
expression vector comprising a floral reproductive gene
linked to an inducible regulatory element, can undergo early
reproductive development at essentially the same time.
Selecting the time of reproductive development can be
useful, for example, in manipulating the time of crop har
vest.
The term “operably linked,” as used in reference to a
regulatory element, such as a promoter, and a nucleic acid
molecule encoding a floral reproductive gene product,
means that the regulatory element confers regulated expres
sion upon the operably linked nucleic acid molecule encod
ing the floral reproductive gene product. Thus, the term
“operably linked”, as used herein, refers to a promoter, such
as for example SEQ ID NO:3 or a functionally equivalent
sequence thereof, linked to a nucleic acid molecule encoding
a floral reproductive gene product, such as SEQ ID NO: 1 or
a functionally equivalent sequence thereof, such that the
promoter may increase or decrease expression of the floral
reproductive gene product. It is recognized that two nucleic
acid molecules that are operably linked contain, at a mini
mum, all elements essential for transcription, including, for
example, a TATA box. One skilled in the art knows, for
example, that a regulatory element that lacks minimal pro
moter elements can be combined with a nucleic acid mol
ecule having minimal promoter elements and a nucleic acid
molecule encoding a floral reproductive gene product such
that expression of the floral reproductive gene product can
be increased in the presence of the appropriate inducing
agent.
The term “inducing agent,” as used herein, means a
substance or condition that effects increased expression of a
nucleic acid molecule operably linked to a particular induc
ible regulatory element as compared to the level of expres
sion of the nucleic acid molecule in the absence of the
inducing agent. An inducing agent can be, for example, a
naturally occurring or synthetic chemical or biological mol
ecule such as a simple or complex organic molecule, a
peptide, a protein or an oligonucleotide that increases
expression of a nucleic acid molecule operably linked to a
particular inducible regulatory element. Examples of such
inducing agents include compounds such as copper sulfate,
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tetracycline or an ecdysone. An inducing agent also can be
a condition such as heat manifest by a certain temperature or
light of a certain wavelength.
One skilled in the art can readily determine the optimum
concentration of an inducing agent needed to produce
increased expression of a nucleic acid molecule operably
linked to an inducible promoter in a transgenic seed plant of
the invention. For conveniently determining the optimum
concentration of inducing agent from a range of useful
concentrations, one skilled in the art can operably link the
particular inducible promoter to a nucleic acid molecule
encoding a reporter gene product such as beta-glucouronidase (GUS) and assay for reporter gene product activity
in the presence of various concentrations of inducing agent
(see, for example, Jefferson et al., EMBO J. 6:3901-3907
(1987), which is incorporated herein by reference).
The nucleic acid molecules encoding floral reproductive
gene products provided herein also can be useful in gener
ating sterile transgenic seed plants and in methods of pro
ducing reproductive sterility in seed plants. The methods of
the invention involve producing a reproductively sterile
transgenic plant, such as a seed plant having a variety of uses
including safely growing transgenic trees in close contact
with interfertile wild trees, increasing wood production and
reducing allergenic pollen production. A method for pro
ducing reproductive sterility in seed plants, which is useful
for transgene containment, can allow, for example, the
introduction of transgenic trees into the environment. Of
particular concern to the introduction of transgenic trees into
the environment is the possibility of enhanced “weediness”
or the movement of transgenes by cross-fertilization into
gene pools of wild relatives. Most commercially grown
forest trees, for example, are grown in close proximity to
interfertile wild populations, and gene flow within and
among tree populations usually is extensive, making the
probability of transgene escape from plantations of fertile
transgenic trees high. Regulatory agencies have based
approval of transgenic tree planting on sexual isolation of
the transgenic species; for example, approval of two field
tests for transgenic poplars by the Animal and Plant Fiealth
Inspection Service (APFilS) was contingent on the trees not
being allowed to flower (see, for example, Strauss et al.,
Molec. Breed 1:5-26 (1995), which is incorporated herein
by reference). Thus, transgene containment through, for
example, the use of sterile transgenic trees is central to the
usefulness of improved transgenic varieties.
Methods of producing reproductively sterile seed plants
also can be useful for increasing wood production, since
substantial energy and nutrients are committed to reproduc
tive development in trees. For example, in trees such as
radiata pine, white spruce, balsam fir and Douglas fir,
reduced growth, as measured by height or stem volume, is
correlated with the early production of cones (Strauss et al.,
supra, 1995). Thus, the methods of the invention, which
prevent flowering or cone development, for example, by
producing reproductive sterility, are useful for growing
substantially larger trees, thus increasing wood production.
A method for producing reproductively sterile plants,
such as seed plants, also can be useful for alleviating
allergies caused by tree pollen. For example, in Japan many
people suffer from allergies caused by the most commonly
planted forest tree, the conifer sugi (Strauss et al., supra,
1995). The methods of the invention, therefore, can be
suitable for preventing pollen formation in seed plants such
as the conifer sugi.
Cosuppression, which relies on expression of a nucleic
acid molecule in the sense orientation, is a well known

methodology that produces coordinate silencing of the intro
duced nucleic acid molecule and the homologous endog
enous gene (see, for example, Flavell, Proc. Natl. Acad. Sci.,
USA 91:3490-3496 (1994), which is incorporated herein by
reference). Although the mechanism of cosuppression is
unknown, cosuppression is induced most strongly by a large
number of transgene copies or by overexpression of trans
gene RNA; cosuppression also can be enhanced by modi
fication of the transgene such that it fails to be translated.
Cosuppression has been used successfully to produce sterile
plants; for example, a sense nucleic acid molecule contain
ing a full-length fbpl coding sequence under the control of
the strong CaMV 35S promoter has been introduced into
petunia. Two of twenty-one transformants exhibited an
abnormal phenotype and contained multiple copies of the
fbpl transgene. Furthermore, fbpl expression was undetect
able in these sterile transgenic plants, indicating that expres
sion of endogenous fbpl was suppressed (Angenent et al.,
The Plant Journal 4:101-112 (1993), which is incorporated
herein by reference).
Antisense nucleic acid molecules, which can act by reduc
ing mRNA translation or by increasing mRNA degradation,
for example, also can suppress gene expression of diverse
genes and seed plant species (see, for example, Kooter et al.,
Mol, Current Opin. Biol. 4:166-171 (1993), which is incor
porated herein by reference; see also Strauss et al., supra,
1995). Antisense nucleic acid molecules previously have
been used to successfully suppress the expression of a
homologous endogenous gene, thereby generating sterile
plants. For example, an antisense chalcone synthase gene
under control of the CaMV 35S promoter with an antherspecific enhancer sequence effectively suppressed endog
enous chalcone synthase expression levels, resulting in male
sterility in transgenic petunia plants (Van der Meer et al., The
Plant Cell Vol 4:253-262 (1992), which is incorporated
herein by reference). Similarly, the full-length tomato TM5
MADS box gene, when placed in antisense orientation under
control of the CaMV 35S promoter, was used to produce
sterile transgenic tomato plants (Pnuell et al., The Plant Cell,
Vol. 6, 175-186 (1994), which is incorporated herein by
reference).
Plant reproductive sterility can also occur through other
traditional molecular methods such as by fusing the pro
moter to a cytotoxic gene such as an RNAse gene or through
using constructs with inverted repeat sequences. Gene sup
pression can also occur by methods such as RNA interfer
ence (RNAi), inverted repeat constructs and post-transcriptional gene silencing (PTGS) processes in which doublestranded (ds) RNA induces the degradation of homologous
RNA sequences. In plants, transcriptional gene silencing
resulting from sequence homology in promoter regions has
also been observed and correlated with increased promoter
methylation. (Kooter et al., Trends Plant Sci., 4, 340-346
(1999).
Plant gene suppression may also result in delayed repro
ductive growth. The delayed reproductive may increase the
length of the vegetative growth stage and cause the plants to
grow faster, since the energy used for development of
flowers and seeds can be saved for vegetative growth. Thus,
delaying or eliminating reproductive growth results in a
higher yield of vegetable species such as spinach, radish,
cabbage, or tree species. In addition, such plants will be
more desirable for as garden and street species, since their
production of pollen alleigens can be reduced or eliminated
The methods of the invention for producing reproductive
sterility rely upon introducing into the genome of a seed
plant one or more sense or antisense nucleic acid molecules
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encoding a floral reproductive gene product, or a function
ally equivalent fragment thereof, such that expression of
PtM3, homolog or ortholog gene products, including expres
sion of endogenous PtM3 or homolog gene products, is
suppressed in the transgenic seed plant. The skilled artisan
will recognize that effective suppression of endogenous
PtM3 or homolog gene product expression depends upon the
one or more introduced nucleic acid molecules having a high
percentage of homology with the corresponding endogenous
gene loci.
A highly homologous nucleic acid molecule is highly
suitable in the methods of the invention. However, a sense
or antisense nucleic acid molecule encoding only a fragment
of PtM3 or its homolog coding sequence, can be useful in
performing the methods of the invention and achieving plant
suppression. For example, leaf-specific inhibition of GUS
gene expression in transgenic tobacco plants using an antisense RNA with a 41-base homology spanning the transla
tion start codon of the gene has been shown. (Cannon et ah,
Plant Mol. Bio., 15:39-47 (1990).
As used herein in reference to a nucleic acid molecule
encoding a floral reproductive gene product, the terms
“sense” and “antisense” have their commonly understood
meanings.
As used herein in reference to a nucleic acid molecule
encoding a floral reproductive gene product, the term “frag
ment” means a portion of the nucleic acid sequence con
taining at least about 50 base pairs to the full-length of the
nucleic acid molecule encoding the floral reproductive gene
product. In contrast to an active fragment or a functionally
equivalent fragment, as defined herein, a fragment of a
nucleic acid molecule encoding a floral reproductive gene
product need not encode a functional portion of a gene
product. A fragment may also be a portion of the nucleic acid
that is less than full-length and comprises at least a minimum
length capable of hybridizing specifically with an PtM3
nucleic acid according to the present invention (or a
sequence complementary thereto) under stringent conditions
as defined below. The length of such a fragment is suitably
15 nucleotides or more, although a shorter nucleic acid can
be employed as a probe or primer if it is shown to specifi
cally hybridize under stringent conditions with a target
nucleic acid by methods well known in the art.
In the methods of the invention for producing reproduc
tive sterility, the sense or antisense nucleic acid molecule is
expressed under control of a strong promoter that is
expressed, at least in part, in floral meristem. The constitu
tive cauliflower mosaic virus 35S promoter (Odell et ah,
supra, 1985), for example, or other strong promoters as
disclosed herein, can be useful in the methods of the
invention. In addition, an RNA polymerase III promoter can
be useful in methods of producing reproductive sterility
using an antisense nucleic acid molecule (see, for example,
Bourque and Folk, Plant Mol. Biol. 19:641-647 (1992),
which is incorporated herein by reference).
As used herein, the term “heterologous regulatory ele
ment” means a regulatory element or a promoter derived
from a different gene than the gene encoding the floral
reproductive gene product to which it is operably linked. A
vector containing a floral reproductive gene, however, con
tains a nucleic acid molecule encoding a floral reproductive
gene product operably linked to a homolgous regulatory
element. Such a vector does not contain a nucleic acid
molecule encoding a floral reproductive gene product oper
ably linked to a heterologous regulatory element and, thus,
is not an expression vector of the invention.

A useful plant gene construct or an expression vector can
contain a constitutive regulatory element for expression of
an exogenous nucleic acid molecule in all or most tissues of
a plant, such as a seed plant. The use of a constitutive
regulatory element can be particularly convenient because
expression from the element is relatively independent of
developmental^ regulated or tissue-specific factors. For
example, the cauliflower mosaic virus 35S promoter (CaMV
35S) is a well-characterized constitutive regulatory element
that produces a high level of expression in all plant tissues
(Odell et al., Nature 313:810-812 (1985), which is incor
porated herein by reference). Furthermore, the CaMV 35S
promoter can be particularly useful due to its activity in
numerous different seed plant species (Benfey and Chua,
Science 250:959-966 (1990), which is incorporated herein
by reference; Odell et al., supra, 1985). Other constitutive
regulatory elements useful for expression in a seed plant
include, for example, the cauliflower mosaic virus 19S
promoter; the Figwort mosaic virus promoter (Singer et al.,
Plant Mol. Biol. 14:433 (1990), which is incorporated herein
by reference); and the nopaline synthase (nos) gene pro
moter (An, Plant Physiol. 81:86 (1986), which is incorpo
rated herein by reference).
In addition, an expression vector of the present invention
can contain a regulated gene regulatory element such as a
promoter or enhancer element. A particularly useful regu
lated promoter is a tissue-specific or a temporal-specific
promoter such as the PtM3 promoter which is both a
tissue-specific and temporal-specific promoter. Another
example of a regulated promoter is a shoot meristemspecific CDC2 promoter (Hemerly et al., Plant Cell.
5:1711-1723 (1993), which is incorporated herein by refer
ence).
As used herein in reference to a particular nucleic acid
molecule or polynucleotide or gene product (i.e., polypep
tide), the term “substantially purified” means that the par
ticular nucleic acid molecule or gene product is in a form
that is relatively free from contaminating lipids, unrelated
gene products, unrelated nucleic acids or other cellular
material normally associated with the particular nucleic acid
molecule or gene product in a cell.
An “active fragment” or a “functionally equivalent frag
ment” refers to a portion of a gene or a gene product that
contains the essential sequences, such as the active site
motif, which provides the sequence fragment with the ability
to perform essentially the same function as the full-length
gene or the gene product. An active fragment incorporated
into the genome of a plant can be identified by phenotypic
analysis of the plant which ectopically expresses the active
fragment producing early flowering, etc. For analysis of a
large number of active fragments of a PtM3 or its homolog,
nucleic acid molecules encoding the active fragments can be
assayed in pools, and active pools subsequently subdivided
to identify the active nucleic acid molecule.
The term “functional portion” or “functional fragment” or
“functional equivalent” of an enzyme is that portion, frag
ment, or equivalent which contains the active site for bind
ing one or more reactants or is capable of improving or
regulating the rate of reaction. The active site may be made
up of separate portions present on one or more polypeptide
chains and will generally exhibit high substrate specificity.
As used herein, the term “variant” covers any sequence
which exhibits at least about 75%, more suitably at least
about 80% and, more suitably yet, at least about 90%
identity to a sequence of the present invention. Sequence
variants include not only genetically engineered sequence
variants, but also naturally occurring variants that arise e.g.,
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within Populus populations, including allelic variants and
polymorphisms, as well as variants that occur in different
genotypes and plant species. Most suitably, a “variant” is
any sequence which has at least about a 99% probability of
being the same as the inventive sequence. Such probability
for DNA sequences is measured by the computer algorithm
FASTA (version 2.0u4, February 1996; Pearson W. R. et ah,
Proc. Natl. Acad. Sci., 85:2444-2448, 1988), the probability
for translated DNA sequences is measured by the computer
algorithm TBLASTX and that for protein sequences is
measured by the computer algorithm BLASTP (Altschul, S.
F. et al. J. Mol. Biol., 215:403-410, 1990). The term
“variants” thus encompasses sequences wherein the prob
ability of finding a match by chance (smallest sum prob
ability) in a database, is less than about 1% as measured by
any of the above tests.
The term a “function-conservative variant” refers to a
polypeptide (or a polynucleotide encoding the polypeptide)
having a given amino acid residue that has been changed
without altering the overall conformation and function of the
polypeptide, including, but not limited to, replacement of an
amino acid with one having similar physico-chemical prop
erties (such as, for example, acidic, basic, hydrophobic, and
the like). Amino acids with have similar physico-chemical
properties are well known in the art. For example, arginine,
histidine and lysine are hydrophilic-basic amino acids and
may be interchangeable. Similarly, isoleucine, a hydropho
bic amino acid, may be replaced with leucine, methionine or
valine.
As used herein, the term “functionally equivalent variant
of PtM3 or its homolog” encompasses an active segment of
PtM3 or its homolog, which is a polypeptide portion of a
PtM3 or its homolog that, when ectopically expressed, alters
normal reproductive plant or tree development such that
altered plant or tree properties are produced. An active
fragment can be, for example, an amino terminal, internal or
carboxy terminal fragment of Aspen PtM3 (SEQ ID NO:4)
that, when ectopically expressed in a plant, alters normal
reproductive development such that plants with altered
reproductive capacity are produced. An active fragment of a
PtM3 gene product can include, for example, the MADS
domain and can have the ability to bind DNA specifically.
The skilled artisan will recognize that a nucleic acid mol
ecule encoding an active segment of PtM3 gene product can
be used to generate a plant of the invention characterized by
producing early flowering, etc. and in the related methods
and kits of the invention described further below.
The term “oligonucleotide” refers to a nucleic acid, gen
erally of at least 10, suitably at least 15, and more suitably
at least 20 nucleotides, that is hybridizable to a genomic
DNA molecule, a cDNA molecule, or an mRNA molecule
encoding a gene, mRNA, cDNA, or other nucleic acid of
interest. Oligonucleotides can be labeled, e.g., with 32Pnucleotides or nucleotides to which a label, such as biotin,
has been covalently conjugated. In one embodiment, a
labeled oligonucleotide can be used as a probe to detect the
presence of a nucleic acid. In another embodiment, oligo
nucleotides (one or both of which may be labeled) can be
used as polymerase chain reaction (PCR) primers, either for
cloning full length or a fragment of PtM3, or to detect the
presence of nucleic acids encoding PtM3. In a further
embodiment, an oligonucleotide of the present invention can
form a triple helix with a PtM3 DNA molecule. In still
another embodiment, a library of oligonucleotides arranged
on a solid support, such as a silicon wafer or chip, can be
used to detect various polymorphisms of interest. Generally,
oligonucleotides are prepared synthetically, suitably on a

nucleic acid synthesizer. Accordingly, oligonucleotides can
be prepared with non-naturally occurring phosphoester ana
log bonds, such as thioester bonds, etc.
The term “non-coding region” refers to that portion of the
gene that does not directly encode a polypeptide. The
boundaries of the non-coding region are located before the
start codon and after the stop codon. The non-coding region
includes the untranslated regions of the genomic DNA.
Also, as used herein, the term “gene” refers to a nucleic
acid fragment that expresses a specific protein including the
regulatory sequences preceding (5' noncoding) and follow
ing (3' noncoding) the coding region. “Native” gene refers to
the gene as found in nature with its own regulatory
sequences.
The term “endogenous gene” refers to the native gene
normally found in its natural location in the genome.
“Exogenous” refers to biological material, such as a
polynucleotide or protein, that has been isolated from a cell
and is then introduced into the same or a different cell. For
example, a polynucleotide encoding a PtM3 gene of the
invention can be cloned from xylem cells of a particular
species of tree, inserted into a plasmid and reintroduced into
xylem cells of the same or different species.
The term “transgene” refers to a homologous or heter
ologous gene that is introduced by gene transfer methods
disclosed herein into the cell, tissue or organ of a host
organism. The term “transgenic” or “transformed” when
referring to a cell or organism, also includes (1) progeny of
the cell or organism and (2) plants produced from a breeding
program employing such a “transgenic” plant as a parent in
a cross and exhibiting an altered phenotype resulting from
the presence of the recombinant PtM3 gene construct.
The term “PtM3 polypeptide” refers to a protein encoded
by an PtM3 gene, including alleles and homologs of PtM3,
functionally equivalent fragments, or by a variant of the
PtM3 gene, having PtM3 biological activity. An PtM3
polypeptide can be isolated from a natural source, produced
by the expression of a recombinant PtM3 nucleic acid, or be
chemically synthesized. Techniques for chemical synthesis
of polypeptides are described, for example, in Merrifield, J.
Amer. Chem. Soc. 85:2149-2156, 1963.
The polypeptides of the present invention can be purified
by any of the means known in the art. Various methods of
protein purification are described, e.g., in Guide to Protein
Purification, ed. Deutscher, Meth. Enzymol. 185, Academic
Press, San Diego, 1990; and Scopes, Protein Purification:
Principles and Practice, Springer Verlag, New York, 1982.
Encompassed by the claimed PtM3 polypeptides are
variant polypeptides in which there have been substitutions,
deletions, insertions or other modifications of the native
PtM3 polypeptide. The variants substantially retain struc
tural and/or biological characteristics and are suitably silent
or conservative substitutions of one or a small number of
contiguous amino acid residues.
The native PtM3 polypeptide sequence can be modified
by conventional methods, e.g., by acetylation, carboxylation, phosphorylation, glycosylation, ubiquitination, and
labeling, whether accomplished by in vivo or in vitro
enzymatic treatment of an PtM3 polypeptide or by the
synthesis of an PtM3 polypeptide using modified amino
acids.
There are a variety of conventional methods and reagents
for labeling polypeptides and fragments thereof. Typical
labels include radioactive isotopes, ligands or ligand recep
tors, fluorophores, chemiluminescent agents, and enzymes.
Methods for labeling and guidance in the choice of labels
appropriate for various purposes are discussed, e.g., in
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Molecular Cloning: A Laboratory Manual, 2nd ed., vol. 1-3,
ed. Sambrook et al., Cold Spring Harbor Laboratory Press:
Cold Spring Harbor, N.Y., 1989; and Current Protocols in
Molecular Biology, ed. Ausubel et al., Greene Publishing
and Wiley-Interscience: New York, 1987 (with periodic
updates).
The present invention also encompasses fragments of
PtM3 polypeptides that lack at least one residue of a native
full-length PtM3 polypeptide yet retain at least one of the
biological activities characteristic of Aspen PtM3. For
example, such a fragment can cause early flowering when
expressed as a transgene in a host plant or possession of a
characteristic immunological determinant. As an additional
example, an immunologically active fragment (i.e., anti
genic determinants or epitopes) of an PtM3 polypeptide is
capable of raising PtM3-specific antibodies in a target
immune system (e.g., murine or rabbit) or of competing with
PtM3 polypeptide for binding to PtM3-specific antibodies,
and is thus useful in immunoassays for the presence of PtM3
polypeptides in a biological sample. Such immunologically
active fragments typically have a minimum size of 7 to 17
amino acids.
The present invention also provides fusion polypeptides
including, for example, heterologous fusion polypeptides,
i.e., an PtM3 polypeptide sequence or fragment thereof and
a heterologous polypeptide sequence, e.g., a sequence from
a different polypeptide. Such heterologous fusion polypep
tides, thus, exhibit biological properties (such as ligand
binding, catalysis, secretion signals, antigenic determinants,
etc.) derived from each of the fused sequences. Fusion
partners include, for example, immunoglobulins, beta galactosidase, trpE, protein A, beta lactamase, alpha amylase,
alcohol dehydrogenase, yeast alpha mating factor, and vari
ous signal and leader sequences which, e.g., can direct the
secretion of the polypeptide. Fusion polypeptides are typi
cally made by the expression of recombinant nucleic acids
or by chemical synthesis.
The term “coding sequence” refers to that portion of the
gene that contains the information for encoding a polypep
tide. The boundaries of the coding sequence are determined
by a start codon at the 5' (amino) terminus and a translation
stop codon at the 3' (carboxyl) terminus. A coding sequence
can include, but is not limited to, prokaryotic sequences,
cDNA from eukaryotic mRNA, genomic DNA sequences
from eukaryotic (e.g., mammalian) DNA, and even synthetic
DNA sequences
The term “encoding” and “coding” refer to the process by
which a gene, through the mechanisms of transcription and
translation, provides the information to a cell from which a
series of amino acids can be assembled into a specific amino
acid sequences to produce an active enzyme. It is understood
that the process of encoding a specific amino acid sequence
includes DNA sequences that may involve base changes that
do not cause a change in the encoded amino acid, or which
involve base changes which may alter one or more amino
acids, but do not affect the functional properties of the
protein encoded by the DNA sequence. It is therefore
understood that the present invention encompasses more
than the specific exemplary sequences. Modifications to the
sequences, such as deletions, insertions or substitutions in
the sequence which produce silent changes that do not
substantially affect the functional properties of the resulting
protein molecule, are also contemplated. For example, alter
ations in the gene sequence which reflect the degeneracy of
the genetic code, or which result in the production of a
chemically equivalent amino acid at a given site, are con
templated. Thus, a codon for the amino acid alanine, a

hydrophobic amino acid, may be substituted by a codon
encoding another less hydrophobic residue, such as glycine,
or a more hydrophobic residue, such as valine, leucine or
isoleucine. Similarly, changes which result in substitution of
one negatively charged residue for another, such as aspartic
acid for glutamic acid, or one positively charged residue for
another, such as lysine for aiginine, can also be expected to
produce a biologically equivalent product. Nucleotide
changes which result in alteration of the N-terminal and
C-terminal portions of the protein molecule would also not
be expected to alter the activity of the protein. In some cases,
it may, in fact, be desirable to make mutants of the sequence
to study the effect of retention of biological activity of the
protein. Each of these proposed modifications is well within
the routine skill in the art, as is the determination of retention
of biological activity in the encoded products. Moreover, the
skilled artisan recognizes that sequences encompassed by
the present invention are also defined by their ability to
hybridize, under stringent condition, with the sequences
exemplified herein.
The term “expression” is meant to refer to the production
of a polypeptide encoded by a gene. “Overexpression” refers
to the production of a polypeptide in transgenic organisms
that exceed levels of production in normal or non-transformed organisms.
The term “% identity” refers to the percentage of the
nucleotides/amino acids of one polynucleotide/polypeptide
that are identical to the nucleotides/amino acids of another
sequence of polynucleotide/polypeptide as identified by a
program such as GAP from Genetics Computer Group
Wisconsin (GCG) package (version 9.0) (Madison, Wis.).
GAP uses the algorithm of Needleman and Wunsch (J. Mol.
Biol. 48: 443-453, 1970) to find the alignment of two
complete sequences that maximizes the number of matches
and minimizes the number of gaps. When parameters
required to run the above algorithm are not specified, the
default values offered by the program are contemplated.
The “% similarity” or “% homology” between two
polypeptide sequences is a function of the number of similar
positions shared by two sequences on the basis of the scoring
matrix used divided by the number of positions compared
and then multiplied by 100. This comparison is made when
two sequences are aligned (by introducing gaps if needed) to
determine maximum homology. PowerBlast program,
implemented by the National Center for Biotechnology
Information, can be used to compute optimal, gapped align
ments. GAP program from Genetics Computer Group Wis
consin package (version 9.0) (Madison, Wis.) can also be
used. GAP uses the algorithm of Needleman and Wunsch {J.
Mol. Biol. 48: 443—453, 1970) to find the alignment of two
complete sequences that maximizes the number of matches
and minimizes the number of gaps. When parameters
required to run the above algorithm are not specified, the
default values offered by the program are contemplated. The
following parameters are used by the GCG program GAP as
default values (for polypeptides): gap creation penalty:12;
gap extension penalty:4; scoring matrix:Blosum62.cpm (lo
cal data file).
A first nucleic acid is “substantially similar” to a second
nucleic acid if, when optimally aligned (with appropriate
nucleotide insertions or deletions) with the other nucleic
acid (or its complementary strand), there is nucleotide
sequence identity in at least about 75%-90% of the nucle
otide bases, and suitably greater than 90% of the nucleotide
bases. (“Substantial sequence complementarity” requires a
similar degree of sequence complementarity.) Sequence
similarity can be determined by comparing the nucleotide
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sequences of two nucleic acids using sequence analysis
software such as the Sequence Analysis Software Package of
the Genetics Computer Group, University of Wisconsin
Biotechnology Center, Madison, Wis.
Alternatively, two nucleic acids are substantially similar if
they hybridize under stringent conditions, as defined below.
A “homolog” of the PtM3 gene is a native gene sequence
isolated from a plant species other than Aspen that has at
least one of the biologically activities of PtM3, e.g., affecting
early flowering in transgenic plants, etc., as discussed above.
The term “ortholog” as used herein refers to orthologous
genes, wherein the gene loci in different species are suffi
ciently similar in their nucleotide sequences to suggest that
they originated from a common ancestral gene. (See PeiShow Juo, Concise Dictionary o f Biomedicine and Molecu
lar Biology (CRC Press 2d ed. 2002)).
An “isolated polynucleotide” refers to a component that is
removed from its original environment (for example, its
natural environment if it is naturally occurring). An isolated
nucleic acid or polypeptide may contains less than about
50%, suitably less than about 75%, and most suitably less
than about 90%, of the cellular components with which it
was originally associated. A polynucleotide amplified using
PCR so that it is sufficiently and easily distinguishable (on
a gel, for example) from the rest of the cellular components
is considered “isolated”. The polynucleotides and polypep
tides of the present invention may be “substantially pure,”
i.e., having the highest degree of purity that can be achieved
using purification techniques known in the art.
A “polynucleotide” is intended to include double or single
stranded genomic and cDNA, RNA, any synthetic and
genetically manipulated polynucleotide, and both sense and
anti-sense strands together or individually (although only
sense or anti-sense stand may be represented herein). This
includes single- and double-stranded molecules, i.e., DNADNA, DNA-RNA and RNA-RNA hybrids, as well as “pro
tein nucleic acids” (PNA) formed by conjugating bases to an
amino acid backbone. This also includes nucleic acids
containing modified bases, for example thio-uracil, thioguanine and fluoro-uracil. Polynucleotide also encompasses
a nucleic acid, the structure of which is not identical to that
of any naturally occurring nucleic acid or to that of any
fragment of a naturally occurring genomic nucleic acid
spanning more than three separate genes. The term, there
fore, covers, for example, (a) a DNA which has the sequence
of part of a naturally occurring genomic DNA molecules but
is not flanked by both of the coding sequences that flank that
part of the molecule in the genome of the organism in which
it naturally occurs; (b) a nucleic acid incorporated into a
vector or into the genomic DNA of a prokaryote or eukary
ote in a manner such that the resulting molecule is not
identical to any naturally occurring vector or genomic DNA;
(c) a separate molecule such as a cDNA, a genomic frag
ment, a fragment produced by PCR, or a restriction frag
ment; and (d) a recombinant nucleotide sequence that is part
of a hybrid gene, i.e., a gene encoding a fusion protein.
Specifically excluded from this definition are nucleic acids
present in mixtures of (i) DNA molecules, (ii) transfected
cells, and (iii) cell clones, e.g., as these occur in a DNA
library such as a cDNA or genomic DNA library.
The term “vector” is a recombinant nucleic acid construct,
such as a plasmid, phage, genome, virus genome, cosmid, or
artificial chromosome, to which a polynucleotide of the
present invention may be attached. In a specific embodi
ment, the vector may bring about the replication of the
attached segment, e.g., in the case of a cloning vector.

The term “expression cassette” or “gene construct” refers
to a polynucleotide which contains both a promoter and a
protein coding sequence such that expression of a given
protein is achieved upon insertion of the expression cassette
into a cell.
DNA constructs incorporating an PtM3 gene or fragment
thereof according to the present invention suitably place the
PtM3 protein coding sequence under the control of an
operably linked promoter that is capable of expression in a
plant cell. Various promoters suitable for expression of
heterologous genes in plant cells are known in the art,
including constitutive promoters, e.g. the cauliflower mosaic
virus (CaMV) 35S promoter, which is expressed in many
plant tissues, organ- or tissue-specific promoters, and tissuespecific or temporal-specific promoters that direct the
expression of the desired gene into specific reproductive
tissue and/or at specific times of the year, for example.
Natural or synthetic nucleic acids according to the present
invention can be incorporated into recombinant nucleic-acid
constructs, typically DNA constructs, capable of introduc
tion into and replication in a host cell. Usually the DNA
constructs will be suitable for replication in a unicellular
host, such as E. coli or other commonly used bacteria, but
can also be introduced into yeast, mammalian, plant or other
eukaryotic cells.
Suitably, such a nucleic-acid construct is a vector com
prising a replication system recognized by the host. For the
practice of the present invention, well-known compositions
and techniques for preparing and using vectors, host cells,
introduction of vectors into host cells, etc. are employed, as
discussed, inter alia, in Sambrook et al., 1989, or Ausubel et
al, 1987.
Methods for chemical synthesis of nucleic acids are
discussed, for example, in Beaucage and Carruthers, Tetra.
Letts. 22:1859-1862, 1981, and Matteucci et al., J. Am.
Chem. Soc. 103:3185, 1981. Chemical synthesis of nucleic
acids can be performed, for example, on commercial auto
mated oligonucleotide synthesizers.
As used herein, “amplified DNA” refers to the product of,
nucleic-acid amplification of a taiget nucleic-acid sequence.
Nucleic-acid amplification can be accomplished by any of
the various nucleic-acid amplification methods known in the
art, including the PCR. A variety of amplification methods
are known in the art and are described, inter alia, in U.S. Pat.
Nos. 4,683,195 and 4,683,202 and in PCR Protocols: A
Guide to Methods and Applications, Innis et al. eds., Aca
demic Press, San Diego, 1990.
The term “hybridization” conditions refers to the condi
tions used herein for isolating a gene, for example, the
conditions are relatively stringent such that non-specific
hybridization is minimized. Appropriate hybridization con
ditions can be determined empirically, or can be estimated
based, for example, on the relative G+C content of the probe
and the number of mismatches between the probe and taiget
sequence, if known. Flybridization conditions can be
adjusted as desired by varying, for example, the temperature
of hybridizing or the salt concentration (Sambrook, supra,
1989).
Flybridization requires that the two polynucleotides con
tain substantially complementary sequences; depending on
the stringency of hybridization, however, mismatches may
be tolerated. Typically, hybridization of two sequences at
high stringency (such as, for example, in an aqueous solu
tion of 0.5xSSC at 65° C.) requires that the sequences
exhibit some high degree of complementarity over their
entire sequence. Conditions of intermediate stringency (such
as, for example, an aqueous solution of 2xSSC at 65° C.) and
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low stringency (such as, for example, an aqueous solution of
2xSSC at 55° C.), require correspondingly less overall
complementarity between the hybridizing sequences.
(lxSSC is 0.15 M NaCl, 0.015 M Na citrate.) As used
herein, the above solutions and temperatures refer to the
probe-washing stage of the hybridization procedure. The
term “a polynucleotide that hybridizes under stringent (low,
intermediate) conditions” is intended to encompass both
single and double-stranded polynucleotides although only
one strand will hybridize to the complementary strand of
another polynucleotide. See also, Sambrook et al., 1989 at
9.47-9.52, 9.56-9.58; Kanehisa, Nuc. Acids Res.
12:203-213, 1984; and Wetmur and Davidson, J. Mol. Biol.
31:349-370, 1968.
The invention also provides a kit for over-expression and
suppressed expression of floral reproductive genes in plants.
The kit may include at least one of the PtM3 gene, the PtM3
gene product, homologs, orthologs, functionally equivalent
fragments, primers, promoters, fragments, antibodies, gene
constructs, expression vectors, host cells, appropriate
reagents to facilitate high efiSciency transformation of a seed
plant and combinations thereof; wherein the over-expression
may result in plants having at least one of accelerated or
early flowering; increased fruit production; increased nut
production; increased seed output; increased branching;
increased flower production; increased fruit yield; increased
flower yield a plant, and a combination thereof and the
suppressed expression may result in at least one of complete
sterility; partial sterility; reduced pollen production,
decreased flowering, increased biomass and combinations
thereof.
If desired, a kit of the invention also can contain a plant
expression vector. As used herein, the term “plant expression
vector” means a self-replicating nucleic acid molecule that
provides a means to transfer an exogenous nucleic acid
molecule into a seed plant host cell and to express the
molecule therein. Plant expression vectors encompass vec
tors suitable for Agrobacterium-mediated transformation,
including binary and cointegrating vectors, as well as vec
tors for physical transformation.
Plant expression vectors can be used for transient expres
sion of the exogenous nucleic acid molecule, or can integrate
and stably express the exogenous sequence. One skilled in
the art understands that a plant expression vector can contain
all the functions needed for transfer and expression of an
exogenous nucleic acid molecule; alternatively, one or more
functions can be supplied in trans as in a binary vector
system for Agrobacterium-mediated transformation.
In addition to containing a nucleic acid molecule encod
ing an PtM3 gene product operatively linked to a regulatory
element, a plant expression vector of the invention can
contain, if desired, additional elements. A binary vector for
Agrobacterium-mediated transformation contains one or
both T-DNA border repeats and can also contain, for
example, one or more of the following: a broad host range
replicon, an ori T for efiScient transfer from E. coli to
Agrobacterium, a bacterial selectable marker such as ampicillin and a polylinker containing multiple cloning sites.
A plant expression vector for physical transformation can
have, if desired, a plant selectable marker and can be based
on a vector such as pBR322, pUC, pGEM and Ml 3, which
are commercially available, for example, from Pharmacia
(Piscataway, N.J.) or Promega (Madison, Wis.). In plant
expression vectors for physical transformation of a seed
plant, the T-DNA borders or the ori T region can optionally
be included but provide no advantage.

The definition of the terms “complement”, “reverse
complement” and “reverse sequence”, as used herein, is best
illustrated by the following example. For the sequence 5'
AGGACC 3', the complement, reverse complement and
reverse sequence are as follows:

5

c o m p le m e n t

3 ' TCCTGG 5 '

r e v e r s e c o m p le m e n t

3 ' GGTCCT 5 '

re v e rse

5 ' CCAGGA 3 '
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Variants of the isolated sequences commercially impor
tant species utilized by the lumber industry, are contem
plated. These include the following gymnosperms, by way
of example: loblolly pine Pinus taeda, slash pine Pinus
elliotti, sand pine Pinus clausa, longleaf pine Pinus palustrus, shortleaf pine Pinus echinata, ponderosa pine Pinus
ponderosa, Jeffrey pine Pinus jeffrey, red pine Pinus resinosa, pitch pine Pinus rigida, jack pine Pinus banksiana,
pond pine Pinus serotina, Eastern white pine Pinus strobus,
Western white pine Pinus monticola, sugar pine Pinus
lambertiana, Virginia pine Pinus virginiana, lodgepole pine
Pinus contorta, Caribbean pine Pinus caribaea, P. pinaster,
Calabrian pine P. brutia, Afghan pine P. eldarica, Coulter
pine P. coulteri, European pine P. nigra and P. sylvestris;
Douglas-fir Pseudotsuga menziesii; the hemlocks which
include Western hemlock Tsuga heterophylla, Eastern hem
lock Tsuga canadensis, Mountain hemlock Tsuga mertensiana; the spruces which include the Norway spruce Picea
abies, red spruce Picea rubens, white spruce Picea glauca,
black spruce Picea mariana, Sitka spruce Picea sitchensis,
Englemann spruce Picea engelmanni, and blue spruce Picea
pungens; redwood Sequoia sempervirens; the true firs
include the Alpine fir Abies lasiocarpa, silver fir Abies
amabilis, grand fir Abies grandis, nobel fir Abies procera,
white fir Abies concolor, California red fir Abies magnifica,
and balsam fir Abies balsamea, the cedars which include the
Western red cedar Thuja plicata, incense cedar libocedrus
decurrens, Northern white cedar Thuja occidentalis, Port
Orford cedar Chamaecyparis lawsoniona, Atlantic white
cedar Chamaecyparis thyoides, Alaska yellow-cedar
Chamaecyparis nootkatensis, and Eastern red cedar Huniperus virginiana; the larches which include Eastern larch
Larix laricina, Western larch Larix occidentalis, European
larch Larix decidua, Japanese larch Larix leptolepis, and
Siberian larch Larix siberica; bold cypress Taxodium distichum and Giant sequoia Sequoia gigantea; and the follow
ing angiosperms, by way of example: Eucalyptus alba, E.
bancroftii, E. botyroides, E. bridgesiana, E. calophylla, E.
camaldulensis, E. citriodora, E. cladocalyx, E. coccifera, E.
curtisii, E. dalrympleana, E. deglupta, E. delagatensis, E.
diversicolor, E. dunnii, E. ficifolia, E. globulus, E. gomphocephala, E. gunnii, E. henryi, E. laevopinea, E. macarthurii,
E. macrorhyncha, E. maculata, E. marginata, E. megacarpa,
E. melliodora, E. nicholii, E. nitens, E. nova-angelica, E.
obliqua, E. obtusiflora, E. oreades, E pauciflora, E. polybractea, E. regnans, E. resinifera, E. robusta, E. rudis, E.
saligna, E. sideroxylon, E. stuartiana, E. tereticornis, E.
torelliana, E. urnigera, E. urophylla, E. viminalis, E. viridis,
E. wandoo and E. youmanni.
The availability of the PtM3 gene and its sequence makes
it possible to obtain homologs or orthologs of the PtM3 gene
in other organisms by conventional methods, through the use
of nucleic acid and antibody probes and DNA primers based
on the PtM3 sequence, as described in greater detail below.
For example, these probes and primers are also useful in

US 7,057,087 B2

27

28

research on the patterns of expression and structure-function
relationships for Aspen PtM3 and its homologs or orthologs,
and for determining the interaction of these genes with other
plant genes involved in floral development.
Nucleic acid probes and primers can be prepared based on
nucleic acids according to the present invention, e.g., the
PtM3 gene of FIG. 1 (SEQ ID NO:l) or the PtM4 gene of
FIG. 2 (SEQ ID NO:2). A “probe” comprises an isolated
nucleic acid attached to a detectable label or reporter mol
ecule well known in the art. Typical labels include radioac
tive isotopes, ligands, chemiluminescent agents, and
enzymes.
“Primers” are short nucleic acids, suitably DNA oligo
nucleotides 15 nucleotides or more in length, which are
annealed to a complementary target DNA strand by nucleic
acid hybridization to form a hybrid between the primer and
the taiget DNA strand, then extended along the target DNA
strand by a polymerase, suitably a DNA polymerase. Primer
pairs can be used for amplification of a nucleic acid
sequence, e.g., by the polymerase chain reaction (PCR) or
other nucleic-acid amplification methods well known in the
art. PCR-primer pairs can be derived from the sequence of
a nucleic acid according to the present invention, for
example, by using computer programs intended for that
purpose such as Primer (Version 0.5, COPYRGT. 1991,
Whitehead Institute for Biomedical Research, Cambridge,
Mass.).
Methods for preparing and using probes and primers are
described, for example, in Sambrook et ah, Molecular
Cloning: A Laboratory Manual, 2nd ed., vol. 1-3, ed.
Sambrook et al., Cold Spring Flarbor Laboratory Press, Cold
Spring Flarbor, N.Y., 1989; Current Protocols in Molecular
Biology, ed. Ausubel et al., Greene Publishing and WileyInterscience, New York, 1987 (with periodic updates); and
Innis et al., PCR Protocols: A Guide to Methods and
Applications, Academic Press: San Diego, 1990. Probes or
primers can be free in solution or covalently or noncovalently attached to a solid support by standard means.
“reproductive unit or structure” of a plant is any totipotent
part or tissue of the plant from which one can obtain a
progeny of the plant, including, for example, seeds, cuttings,
buds, bulbs, somatic embryos, etc.
The term “female reproductive structure” as used herein
means those portions of a plant which compose the carpel,
or gynoecium (an old established term used with regard to
the gynoecium is “pistil”). The carpel of a flower of a plant
includes but is not limited to a stigma, style, ovary, and cells
or tissues which comprise the stigma, style and ovary.
As used herein, the term “antibody” is used in its broadest
sense to include naturally occurring and non-naturally
occurring polyclonal and monoclonal antibodies, as well as
a polypeptide fragment of an antibody that retains a specific
binding activity of at least about 1x10s 1/M for a PtM3 gene
product (SEQ ID NO:4) or a homolog thereof (SEQ ID
NO: 5), such as PtM4 gene product. One skilled in the art
would recognize that an antibody fragment such as a Fab,
F(ab')2or Fv fragment can retain specific binding activity for
a PtM3 gene product or a homolog thereof, thus, is included
within the definition of an antibody. A non-naturally occur
ring antibody, or fragment thereof, such as a chimeric
antibody or humanized antibody also is included within the
meaning of the term antibody. Such a non-naturally occur
ring antibody can be constructed using solid phase peptide
synthesis, produced recombinantly or obtained, for example,
by screening a combinatorial library consisting of variable

heavy chains and variable light chains as described by Fluse
et al., Science 246:1275-1281 (1989), which is incorporated
herein by reference.
An antibody “specific for” a polypeptide, or that “spe
cifically binds” a polypeptide, binds with substantially
higher afiSnity to that polypeptide than to an unrelated
polypeptide. An antibody specific for a polypeptide also can
have specificity for a related polypeptide. For example, an
antibody specific for an Aspen PtM3 polypeptide or a
homolog thereof, can specifically bind another plant PtM3
polypeptide or a homolog, such as an angiosperm, specifi
cally, such as Arabidopsis thaliana PtM3 polypeptide or a
tobacco PtM3 polypeptide. An antibody specific for an
antigenic determinant or a epitopic region which consists of
virtually any detectable epitope varying in amino acid
length, that may be employed as a screenable marker, can be
selected from the extremely wide variety of antigemantibody combinations known to those of skill in the art. The
unique extracellular epitope, whether derived from PtM3 or
any other protein or epitopic substance, can then be straight
forwardly detected using antibody labeling in conjunction
with chromogenic or fluorescent adjuncts.
The invention encompasses the production of an antibody
to the PtM3 protein, homologs and orthologs and functional
fragments thereof. Monoclonal or polyclonal antibodies may
be produced to either the normal PtM3 protein or mutated
forms of this protein. The determination that an antibody
specifically detects the PtM3 protein is made by any one of
a number of standard immunoassay methods; for instance,
the Western blotting technique (Sambrook et al., 1989). To
determine that a given antibody preparation (such as one
produced in a mouse) specifically detects the PtM3 protein
by Western blotting, total cellular protein is extracted from
rice cells and electrophoresed on a sodium dodecyl sulfatepolyacrylamide gel. The proteins are then transferred to a
membrane (for example, nitrocellulose) by Western blotting,
and the antibody preparation is incubated with the mem
brane. After washing the membrane to remove non-specifically bound antibodies, the presence of specifically bound
antibodies is detected by the use of an anti-mouse antibody
conjugated to an enzyme such as alkaline phosphatase;
application of the substrate 5-bromo-4-chloro-3-indolyl
phosphate/nitro blue tetrazolium results in the production of
a dense blue compound by immuno-localized alkaline phos
phatase. Antibodies which specifically detect the PtM3
protein will, by this technique, be shown to bind to the PtM3
protein band (which will be localized at a given position on
the gel determined by its molecular weight). Non-specific
binding of the antibody to other proteins may occur and may
be detectable as a weak signal on the Western blot. The
non-specific nature of this binding will be recognized by one
skilled in the art by the weak signal obtained on the Western
blot relative to the strong primary signal arising from the
specific antibody-PtM3 protein binding.
Substantially pure PtM3 protein suitable for use as an
immunogen is isolated from rice cells or other cells in which
it is produced, as described. Concentration of protein in the
final preparation is adjusted, for example, by concentration
on an Amicon filter device, to the level of a few micrograms
per milliliter. Monoclonal or polyclonal antibody to the
protein can then be prepared as follows:
Monoclonal antibody to epitopes of the PtM3 protein
identified and isolated as described can be prepared from
murine hybridomas according to the classical method of
Kohler and Milstein (1975). Nature 256:495, or derivative
methods thereof. Briefly, a mouse is repetitively inoculated
with a few micrograms of the selected protein over a period
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of a few weeks. The mouse is then sacrificed, and the
antibody-producing cells of the spleen isolated. The spleen
cells are fused by means of polyethylene glycol with mouse
myeloma cells, and the excess unfused cells destroyed by
growth of the system on selective media comprising aminopterin (HAT media). The successfully fused cells are
diluted and aliquots of the dilution placed in wells of a
microtiter plate where growth of the culture is continued.
Antibody-producing clones are identified by detection of
antibody in the supernatant fluid of the wells by immunoas
say procedures, such as ELISA, as originally described by
Engvall (1980). Enzymol. 70:419, and derivative methods
thereof. Selected positive clones can be expanded and their
monoclonal antibody product harvested for use. Detailed
procedures for monoclonal antibody production are
described in Harlow and Lane (1988). Antibodies, A Labo
ratory Manual, Cold Spring Harbor Laboratory, New York.
Polyclonal antiserum containing antibodies to heterog
enous epitopes of a single protein can be prepared by
immunizing suitable animals with the expressed protein,
which can be unmodified or modified to enhance immunogenicity. Effective polyclonal antibody production is
affected by many factors related both to the antigen and the
host species. For example, small molecules tend to be less
immunogenic than others and may require the use of carriers
and adjuvant. Also, host animals vary in response to site of
inoculations and dose, with both inadequate or excessive
doses of antigen resulting in low titer antisera. Small doses
(ng level) of antigen administered at multiple intradermal
sites appears to be most reliable. An effective immunization
protocol for rabbits can be found in Vaitukaitis et al. (1971).
J. Clin. Endocrinol. Metab. 33:988-991.
Booster injections can be given at regular intervals, and
antiserum harvested when antibody titer thereof, as deter
mined semi-quantitatively, for example, by double immun
odiffusion in agar against known concentrations of the
antigen, begins to fall. See, for example, Ouchterlony et al.
(1973). In Handbook o f Experimental Immunology, Wier, D.
(ed.) chapter 19. Blackwell. Plateau concentration of anti
body is usually in the range of 0.1 to 0.2 mg/ml of serum.
Affinity of the antisera for the antigen is determined by
preparing competitive binding curves, as described, for
example, by Fisher (1980). Manual o f Clinical Immunology,
Ch. 42.
A third approach to raising antibodies against the PtM3
protein is to use synthetic peptides synthesized on a com
mercially available peptide synthesizer based upon the pre
dicted amino acid sequence of the PtM3 protein.
Antibodies may be raised against the PtM3 protein by
subcutaneous injection of a DNA vector which expresses the
PtM3 protein into laboratory animals, such as mice. Deliv
ery of the recombinant vector into the animals may be
achieved using a hand-held form of the Biolistic system as
described by Tang et al. (1992). Nature (London) 356:
152-154.
Antibody preparations prepared according to these pro
tocols are useful in quantitative immunoassays which deter
mine concentrations of antigen-bearing substances in bio
logical samples; they are also used semi-quantitatively or
qualitatively to identify the presence of antigen in a biologi
cal sample.
The term “in situ hybridization” refers to a number of
techniques have been developed in which nucleic-acid
probes are used to locate specific DNA sequences on intact
chromosomes in situ, a procedure called “in situ hybridiza
tion.” See, e.g., Pinkel et al., Proc. Natl. Acad. Sci. USA
85:9138-9142, 1988 (regarding fluorescence in situ hybrid

ization), and Lengauer et al., Hum. Mol. Genet. 2:505-512,
1993 (regarding “chromosomal bar codes”). Well-known
methods for in situ hybridization and for the preparation of
probes or primers for such methods are employed in the
practice of the present invention, including direct and indi
rect in situ hybridization methods.
All publications cited herein are incorporated by reference
to the same extent as if each individual publication was
specifically and individually indicated to be incorporated by
reference. The invention now being fully described, it will
be apparent to one of ordinary skill in the art that many
changes and modifications can be made thereto without
departing from the spirit or scope of the claims.
The terms used in this specification generally have their
ordinary meanings in the art, within the context of the
invention, and in the specific context where each term is
used. Certain terms are defined above, or elsewhere in the
specification, to provide additional guidance to the person of
skill in the art in describing the compositions and methods
of the invention and how to make and use them. It will be
appreciated that the same thing can be said in more than one
way. Consequently, alternative language and synonyms may
be used for any one or more of the terms discussed herein,
nor is any special significance to be placed upon whether or
not a term is elaborated or discussed herein. Synonyms for
certain terms are provided. A recital of one or more syn
onyms does not exclude the use of other synonyms. The use
of examples anywhere in this specification, including
examples of any terms discussed herein, is illustrative only,
and in no way limits the scope and meaning of the invention
or of any exemplified term. Likewise, the invention is not
limited to the preferred embodiments.
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Once a nucleic acid encoding a protein involved in the
determination of a particular plant characteristic, such as
flowering, has been isolated, standard techniques may be
used to express the nucleic acid in transgenic plants in order
to modify that particular plant characteristic. One approach
is to clone the nucleic acid into a vector, such that it is
operably linked to control sequences (e.g., a promoter)
which direct expression of the nucleic acid in plant cells. The
transformation vector is then introduced into plant cells by
one of a number of techniques (e.g., Agrobacterium-medi
ated transformation) and progeny plants containing the
introduced nucleic acid are selected. All or part of the
transformation vector may stably integrate into the genome
of the plant cell. That part of the vector which integrates into
the plant cell and which contains the introduced nucleic acid
and associated sequences for controlling expression (the
introduced “transgene”) may be referred to as the transgenic
expression cassette.
Selection of progeny plants containing the introduced
transgene may be made based upon the detection of an
altered phenotype. Such a phenotype may result directly
from the nucleic acid cloned into the transformation vector
or may manifest as enhanced resistance to a chemical agent
(such as an antibiotic) as a result of the inclusion of a
dominant selectable marker gene incorporated into the trans
formation vector.
The choice of (a) control sequences and (b) how the
nucleic acid (or selected portions of the nucleic acid) are
arranged in the transformation vector relative to the control
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sequences determine, in part, how the plant characteristic
affected by the introduced nucleic acid is modified. For
example, the control sequences may be tissue specific, such
that the nucleic acid is only expressed in particular tissues of
the plant (e.g., reproductive tissues) and so the affected
characteristic will be modified only in those tissues. The
nucleic acid sequence may be arranged relative to the
control sequence such that the nucleic acid transcript is
expressed normally, or in an antisense orientation. Expres
sion of an antisense RNA that is the reverse complement of
the cloned nucleic acid will result in a reduction of the
targeted gene product (the targeted gene product being the
protein encoded by the plant gene from which the introduced
nucleic acid was derived). Over-expression of the intro
duced nucleic acid, resulting from a plus-sense orientation
of the nucleic acid relative to the control sequences in the
vector, may lead to an increase in the level of the gene
product, or may result in a reduction in the level of the gene
product due to co-suppression (also termed “sense suppres
sion”) of that gene product. In another approach, the nucleic
acid sequence may be modified such that certain domains of
the encoded peptide are deleted. Depending on the domain
deleted, such modified nucleic acid may act as dominant
negative mutations, suppressing the phenotypic effects of
the corresponding endogenous gene.
Successful examples of the modification of plant charac
teristics by transformation with cloned nucleic acid
sequences are replete in the technical and scientific litera
ture. Selected examples, which serve to illustrate the level of
knowledge in this field of technology include:
U.S. Pat. No. 5,432,068 (control of male fertility using
externally inducible promoter sequences);
U.S. Pat. No. 5,686,649 (suppression of plant gene
expression using processing-defective RNA con
structs);
U.S. Pat. No. 5,659,124 (transgenic male sterile plants);
U.S. Pat. No. 5,451,514 (modification of lignin synthesis
using antisense RNA and co-suppression);
U.S. Pat. No. 5,443,974 (modification of saturated and
unsaturated fatty acid levels using antisense RNA and
co-suppression);
U.S. Pat. No. 5,530,192 (modification of amino acid and
fatty acid composition using antisense RNA);
U.S. Pat. No. 5,455,167 (modification of medium chain
fatty acids)
U.S. Pat. No. 5,231,020 (modification of flavonoids using
co-suppression);
U.S. Pat. No. 5,583,021 (modification of virus resistance
by expression of plus-sense RNA); and
Mizukami et al. (1996). Plant Cell 8:831-845 (dominant
negative mutations in floral development using partial
deletions of AG).
These examples include descriptions of transformation
vector selection, transformation techniques and the produc
tion of constructs designed to over-express an introduced
nucleic acid, dominant negative mutant forms, untranslat
able RNA forms or antisense RNA. In light of the foregoing
and the provision herein of the PtM3 and PtM4 cDNA and
gene sequences, it is apparent that one of skill in the art may
be able to introduce these cDNAs or genes, or derivative
forms of these sequences (e.g., antisense forms), into plants
in order to produce plants having modified fertility charac
teristics, particularly sterility. This Example provides a
description of the approaches that may be used to achieve
this goal. For convenience, the PtM3 and PtM4 cDNAs and
genes disclosed herein will be generically referred to as the
“floral reproductive genes,” and the encoded polypeptides as

the “floral reproductive gene products” or “floral reproduc
tive polypeptide”. Example 6 provides an exemplary illus
tration of how an antisense or inverted repeat form of one of
these floral reproductive genes, specifically the PTD cDNA,
may be introduced into angiosperms such as tobacco and
Arabidopsis using Agrobacterium transformation, in order
to produce genetically engineered sterile angiosperms.
Example 5 provides an exemplary illustration of how
increased expression of PtM3 cDNA may be produced and
introduced into angiosperm species to produce modified
fertility characteristics, such as early flowering, increased
branching, increased flower pod production, and conversion
of axillary meristems to floral meristems.
a. Vector Construction, Choice of Promoters
A number of recombinant vectors suitable for stable
transfection of plant cells or for the establishment of trans
genic plants have been described including those described
in Pouwels et al. (1987). Cloning Vectors: A Laboratory
Manual, 1985 supplement; and Weissbach and Weissbach
(1989). Methods for Plant Molecular Biology, Academic
Press. Typically, plant transformation vectors include one or
more cloned plant genes (or cDNAs) under the transcrip
tional control of 5' and 3' regulatory sequences and a
dominant selectable marker. Such plant transformation vec
tors typically also contain a promoter regulatory region (e.g.,
a regulatory region controlling inducible or constitutive,
environmentally or developmentally regulated, or cell-, tis
sue-, or temporal-specific expression), a transcription initia
tion start site, a ribosome binding site, an RNA processing
signal, a transcription termination site, and/or a polyadenylation signal.
Examples of plant promoters which may be useful for
expressing the floral reproductive genes are provided herein
above.
The promoter regions of the PtM3 or PtM4 gene
sequences confer floral-specific (or floral-enriched) expres
sion in Populus. Accordingly, these native promoters may be
used to obtain floral-specific (or floral-enriched) expression
of the introduced transgene.
Plant transformation vectors may also include RNA pro
cessing signals, for example, introns, which may be posi
tioned upstream or downstream of the ORF sequence in the
transgene. In addition, the expression vectors may also
include additional regulatory sequences from the 3'-untranslated region of plant genes, e.g., a 3' terminator region to
increase mRNA stability of the mRNA, such as the PI-II
terminator region of potato or the octopine or nopaline
synthase 3' terminator regions.
Also, plant transformation vectors may also include domi
nant selectable marker genes to allow for the ready selection
of transformants. Such genes include those encoding anti
biotic resistance genes (e.g., resistance to hygromycin, kanamycin, bleomycin, G418, streptomycin or spectinomycin)
and herbicide resistance genes (e.g., phosphinothricin
acetyltransferase).
b. Arrangement of Floral Reproductive Gene Sequence in
Vector
Modified fertility characteristics in plants may be
obtained using the floral reproductive gene sequences dis
closed herein in a variety of forms. Over-expression, sensesuppression, antisense RNA, inverted repeats and dominant
negative mutant forms of the disclosed floral reproductive
gene sequences may be constructed in order to modulate or
supplement the expression of the corresponding endogenous
floral reproductive genes, and thereby to produce plants
having modified fertility characteristics. Alternatively, the
floral-specific (or floral-enriched) expression conferred by
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the promoters of the disclosed floral reproductive genes may
be employed to obtain corresponding expression of cyto
toxic products. Such constructs will comprise the appropri
ate floral reproductive promoter sequence operably linked to
a suitable open reading frame (discussed further below) and
will be useful in genetic ablation approaches to engineering
sterility in plants.
i. Modulation/Supplementation of Floral Reproductive
Gene Expression
The particular arrangement of the floral reproductive gene
sequence in the transformation vector will be selected
according to the type of expression of the sequence that is
desired.
Enhanced expression of a floral reproductive gene may be
achieved by operably linking the floral reproductive gene to
a constitutive high-level promoter such as the CaMV 35S
promoter. As noted below, modified activity of a floral
reproductive gene product in plants may also be achieved by
introducing into a plant a transformation vector containing a
variant form of a floral reproductive gene, for example a
form which varies from the exact nucleotide sequence of the
disclosed floral reproductive gene.
A reduction in the activity of a floral reproductive
polypeptide in the transgenic plant may be obtained by
introducing into plants antisense constructs based on the
floral reproductive gene sequence. For expression of antisense RNA, the floral reproductive gene is arranged in
reverse orientation relative to the promoter sequence in the
transformation vector. The introduced sequence need not be
the full-length floral reproductive gene, and need not be
exactly homologous to the floral reproductive gene found in
the plant type to be transformed. Generally, however, where
the introduced sequence is of shorter length, a higher degree
of homology to the native floral reproductive gene sequence
will be needed for effective antisense suppression. Suitably,
the introduced antisense sequence in the vector will be at
least 50 nucleotides in length, and improved antisense
suppression will typically be observed as the length of the
antisense sequence increases. Suitably, the length of the
antisense sequence in the vector will be greater than 100
nucleotides. Transcription of an antisense construct as
described results in the production of RNA molecules that
are the reverse complement of mRNA molecules transcribed
from the endogenous floral reproductive gene in the plant
cell. Although the exact mechanism by which antisense
RNA molecules interfere with gene expression has not been
elucidated, it is believed that antisense RNA molecules bind
to the endogenous mRNA molecules and thereby inhibit
translation of the endogenous mRNA.
Suppression of endogenous floral reproductive polypep
tide activity can also be achieved using ribozymes.
Ribozymes are synthetic RNA molecules that possess highly
specific endoribonuclease activity. The production and use
of ribozymes are disclosed in U.S. Pat. No. 4,987,071 and
U.S. Pat. No. 5,543,508. The inclusion of ribozyme
sequences within antisense RNAs may be used to confer
RNA cleaving activity on the antisense RNA, such that
endogenous mRNA molecules that bind to the antisense
RNA are cleaved, which in turn leads to an enhanced
antisense inhibition of endogenous gene expression.
Constructs in which the floral reproductive gene (or
variants thereon) are over-expressed may also be used to
obtain co-suppression of the endogenous floral reproductive
gene in the manner described in U.S. Pat. No. 5,231,021.
Such co-suppression (also termed sense suppression) does
not require that the entire floral reproductive cDNA or gene
be introduced into the plant cells, nor does it require that the

introduced sequence be exactly identical to the endogenous
floral reproductive gene. Flowever, as with antisense sup
pression, the suppressive efficiency will be enhanced as (1)
the introduced sequence is lengthened and (2) the sequence
similarity between the introduced sequence and the endog
enous floral reproductive gene is increased.
Constructs expressing an untranslatable form of the floral
reproductive gene mRNA may also be used to suppress the
expression of endogenous floral reproductive genes. Meth
ods for producing such constructs are described in U.S. Pat.
No. 5,583,021. Such constructs are made by introducing a
premature stop codon into the floral reproductive ORF.
Finally, dominant negative mutant forms of the disclosed
sequences may be used to block endogenous floral repro
ductive polypeptide activity using approaches similar to that
described by Mizukami et al. (1996). Plant Cell 8:831-845.
Such mutants require the production of mutated forms of
the floral reproductive polypeptide that bind either to an
endogenous binding target (for example, a nucleic acid
sequence in the case of floral reproductive polypeptides,
such as PtM3 and PtM4, that function as transcription
factors) or to a second polypeptide sequence (such as
transcription co-factors), but do not function normally after
such binding (i.e. do not function in the same manner as the
non-mutated form of the polypeptide). By way of example,
such dominant mutants can be constructed by deleting all or
part of the C-terminal domain of a floral reproductive
polypeptide, leaving an intact MADS domain. Polypeptides
lacking all or part of the C-terminal region may bind to the
appropriate DNA target, but are unable to interact with
protein co-factors, thereby blocking transcription. Alterna
tively, dominant negative mutants may be produced by
deleting all or part of the MADS domain, or all or part of the
K-domain.
ii. Genetic Ablation
An alternative approach to modulating floral development
is to specifically target a cytotoxic gene product to the floral
tissues. This may be achieved by producing transgenic
plants that express a cytotoxic gene product under the
control of a tissue- and temporal-specific promoter, such as
the promoter region of PtM3 as disclosed herein. The
promoter region of this gene sequence is generally contained
within the first 150 base pairs of sequence upstream of the
open reading frame, although tissue- and temporal-specific
expression may be conferred by using smaller regions of this
sequence. Thus, regions as small as the first 50 base pairs of
sequence upstream of the open reading frame may be
effective in conferring tissue- and temporal-specific expres
sion. Flowever, longer regions, such as at least 100, 150, 200
or 250 base pairs of the upstream sequences are preferred.
A number of known cytotoxic gene products may be
expressed under the control of the disclosed promoter
sequences of the floral reproductive gene. These include:
RNases, such as barnase from Bacillus amyloliquefaciens
and RNase-Tl from Aspergillus; Mariani et al. (1992). A
chimeric ribonuclease-inhibitor gene restores fertility to
male-sterile plants. Nature 357:384-387; ADP-ribosyltransferase (Diphtheria toxin A chain); Kandasamy et al.
(1993). Ablation of papillar cell finction in Brassica flowers
results in the loss of stigma receptivity to pollination. Plant
Cell 5:263-275; RolC from Agrobacterium rhizogenes;
Schmulling et al. (1993). Resoration of fertility by antisense
RNA in genetically engineered male sterile tobacco plants.
Mol. Gen. Genet. 237-385-394; DTA (diphtheria toxin A);
Pappenheimer (1977). Diphtheria toxin. Annu. Rev. Biochem. 46:69-94; and glucanase (Worrall et al. (1992). Pre
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mature dissolution of the microporocyte callose wall causes
male sterility in transgenic tobacco. Plant Cell 4:759-771).
c. Transformation and Regeneration Techniques
Constructs designed as discussed above to modulate or
supplement expression of native floral reproductive genes in
plants, or to express cytotoxins in a tissue- and temporalspecific manner can be introduced into plants by a variety of
means. Transformation and regeneration of both monocotyledonous and dicotyledonous plant cells is now routine, and
the selection of the most appropriate transformation tech
nique will be determined by the practitioner. The choice of
method will vary with the type of plant to be transformed;
those skilled in the art will recognize the suitability of
particular methods for given plant types. Suitable methods
may include, but are not limited electroporation of plant
protoplasts; liposome-mediated transformation; polyethyl
ene mediated transformation; transformation using viruses;
micro-injection of plant cells; micro-projectile bombard
ment of plant cells; vacuum infiltration; and Agrobacterium
tumefaciens (AT) mediated transformation. Typical proce
dures for transforming and regenerating plants are described
in the patent documents listed at the beginning of this
section.
Methods that are particularly suited to the transformation
of woody species include (for Picea species) methods
described in Ellis et al. (1993). Bio/Technology 11:84-89;
and (for Populus species) the use of .4. tumefaciens (Stettler
(1993). Popular Molecular Network Newsletter 1(1), Col
lege of Forest Resources AR-10, University of Washington,
Seattle, Wash.; Strauss et al. (1995a). Molecular Breeding
1:5-26; Strauss et al. (1995b). TGERC Annual Report:
1994-1995. Forest Research Laboratory, Oregon State Uni
versity), A. rhizogenes (Flan et al. (1996). Cellular and
molecular biology of Agrobacterium-mediated transforma
tion of plants and its application to genetic transformation of
Populus. In: Stettler et al. [eds.] Biology of Populus and its
Implications for Management and Conservation, Part I,
Chapter 9, pp. 201-222, NRC Research Press, Nat. Res.
Coun. of Canada, Ottawa, Ontario) and biolistics (McCown
et al. (1991), stable transformation of Populus and incorpo
ration of pest resistance by electric discharge particle accel
eration. Plant Cell Rep. 9:590-594).
d. Selection of Transformed Plants
Following transformation and regeneration of plants with
the transformation vector, transformed plants are suitably
selected using a dominant selectable marker incorporated
into the transformation vector. Typically, such a marker will
confer antibiotic resistance on the seedlings of transformed
plants, and selection of transformants can be accomplished
by exposing the seedlings to appropriate concentrations of
the antibiotic.
After transformed plants are selected and grown to matu
rity, the effect on fertility can be determined by visual
inspection of floral morphology, including the determination
of the production of pollen or ova. In addition, the effect on
the activity of the endogenous floral reproductive gene may
be directly determined by nucleic acid analysis (hybridiza
tion or PCR methodologies) or immunoassay (western blot)
of the expressed protein. Antisense or sense suppression of
the endogenous floral reproductive gene may be detected by
analyzing mRNA expression on Northern blots or by reverse
transcription polymerase chain reaction (RT-PCR).

EXAMPLE 2
Cloning and Sequence Analysis of PtM3 and PtM4
cDNA
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MADS-box cDNA homologs were cloned from male
(PtM3) and female (PtM4) aspen (Populus tremuloides).
PtM3 and PtM4 clones were first isolated by Reverse
transcription-Polymerase chain reaction (RT-PCR) using
RNA extracted from Populus cells as a template. The gene
sequences may also be directly amplified using Populus
genomic DNA as a template. Methods and conditions for
both direct PCR and RT-PCR are known in the art and are
described in Innis et al. (1990). PCR Protocols, A Guide to
Methods and Applications, Innis et al. [eds.], Academic
Press, Inc., San Diego, Calif. The RT-PCR procedure was
followed by screening a cDNA library from developing male
and female aspen flowers (Ausubel et al., 1989. Current
Protocols, Wiley Publishers, NY). Suitable plant cDNA and
genomic libraries for direct PCR include Populus libraries
made by methods described therein. Other tree cDNA and
genomic libraries may also be screened in order to, amplify
orthologous cDNAs of tree species, such as Pinus and
Eucalyptus.
The full-length nucleotide sequences of PTM3 and PTM4
was obtained by using similar PCR primer sets. One set of
external PCR primers was used to obtain the PCR product
and two sets of nested internal PCR primers were used to
confirm the PCR products obtained from the external prim
ers. The oligonucleotide sequences of the external primers
are as follows: 5' primer (cDNA5'Sl)-5' GTTAAGGAATATGGGGAGAGGTAGAGTGG 3' (SEQ ID NO:6)
and 3' primer (cDNA3'ASb)-5' GTCCCTGGCTAAAGTTCTGAAATCCAGCCAC 3' (SEQ ID NO:7). The 5' inter
nal set of primers used to confirm the PCR products obtained
from the external primers are as follows: 5' internal primer
1 (cDNA5'S2)-5' GATAGAGAACAAGATAAACAGGCAGGTGA 3' (SEQ ID NO:8) and 3' internal primer 2
(FAGL4-ASl)-5' GTTCCTCTGAGTTCGTTGTAGGGC 3'
(SEQ ID NO:9). The 3' internal set of primers used to
confirm the PCR products obtained from the external prim
ers are as follows: 5' internal primer 1 (FAGL4-Sl)-5'
CAAGATTTGAGGCCCTACAACGA 3' (SEQ ID NO: 10)
and 3' internal primer 2 (cDNA3'ASb)-5' GTCCCTGGCTAAAGTTCTGAAATCCAGCCAC 3' (SEQ ID
NO: 11). These primers are illustrative only; it will be
appreciated by one skilled in the art that many different
primers may be derived from a cDNA or a full-length gene
sequence in order to amplify particular regions. Suitable
amplification conditions for PtM3 and PtM4 include those
described herein (See, e.g., Innis et al. (1990)). As is well
known in the art, amplification conditions may nee d to be
varied in order to amplify orthologous genes where the
sequence identity is not 100%; in such cases, the use of
nested primers, as described in (Ausbel 1989) may be
beneficial. Resequencing of PCR products obtained by these
amplification procedures is recommended; this will facilitate
confirmation of the amplified cDNA sequence and will also
provide information on natural variation on this sequence in
different ecotypes, cultivars and plant populations.
Oligonucleotides that are derived from the PtM3 or PtM4
cDNA and gene sequences and which are suitable for use as
PCR primers to amplify corresponding nucleic acid
sequences are encompassed within the scope of the present
invention. Such oligonucleotide primers will comprise a
sequence of 15-20 consecutive nucleotides of the selected
cDNA or gene sequence. To enhance amplification speci
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ficity, primers comprising at least 25, 30, 35, 50 or 100
consecutive nucleotides of the PtM3 or PtM4 gene or cDNA
sequences may be used.
The nucleotide sequences of PtM3 and PtM4 cDNAs and
the PtM3 5' untranslated region containing the promoter
(See Example 3) were determined using the dideoxy chain
termination method (Sanger et al., 1977. Proc. Natl. Acad.
Sci. 74: 5463-5467). FIG. 1 illustrates the polynucleotide
(SEQ ID NO:l) sequence and the corresponding amino acid
(SEQ ID NO:4) sequence of Aspen PtM3. FIG. 2 shows the
polynucleotide (SEQ ID NO:2) sequence and the corre
sponding amino acid (SEQ ID NO:5) sequence of Aspen
PtM4. FIG. 3 shows the predicted amino acid sequence
alignment between Aspen PtM3 and Aspen PtM4, wherein
the sequence identity between the two homologs is found to
be 97% using the Clustal W sequence alignment algorithm.
Based on sequence level similarity, it was determined that
PtM3 and PtM4 belong to the SEP1/2 family of genes,
which includes AGL2/SEP1, AGL4/SEP2 from Arabidopsis, and DEFF149 from Antirrhinum (Pelaz et al., 2000;
Angenent et al, 1992; Davies et al., 1996) (FIG. 4). Flowever, at the amino acid level, it appears that PtM3/PtM4
share 76% identity with AGL2/SEP1, 75% with AGL4/
SEP2, and 68% with DEFF149. Regardless, it should be
noted that this is the first instance where PtM3 and PtM4
have been identified to have the same MADS-box family
gene from the male and female flowers of a dioecious tree
species. Both, PtM3 and PtM4 were found to be expressed
during early stages of flower development in aspen and thus
have potential to control flowering in aspen and other related
tree species. Furthermore, while the PtM3 and PtM4
sequences show some similarity to Arabidopsis Sepellata
genes (See, Pelaz et al) the % sequence identity is not
enough to classify them as Sepallata group genes.

ductive tissue targeting and alteration of the timing of gene
expression of desired genes and gene products as described
below in Examples 4-6.
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EXAMPLE 3
PtM3 Promoter Isolation and Sequence Analysis
The promoter region for PtM3 was also cloned. The
promoter region of PtM3 was isolated using the Genome
Walker kit purchased from Clontech (Clontech, Calif.). The
promoter region of PtM3 contained the motifs characteristic
of MADS-box gene promoters such as CArG boxes as
determined by searching with the Genomatix software at
http://www.genomatix.de/mat_fam. (See, GenomatixUSA,
1776 Mentor Avenue, Cincinnati, Ohio, 45212, USA; TollFree: (888) 236-3029)
FIG. 5 sets forth the 5'-untranslated region (UTR) which
includes the polynucleotide sequence of the PtM3 promoter
along with the intron sequence. The PtM3 promoter contains
a MADS-box sequence motif from nucleotides 1153 to
1441, which is believed to regulate gene expression by
binding to sites, known as CArG boxes, TATA sequences,
etc., present in the promoter regions of plant MADS-box
genes (Riechmann et al., Biol. Chem. 378:1079-1101
(1998). The PtM3 promoter region sequence may be very
useful in determining how PtM3 related genes are regulated
in trees and how their expression is modulated during
dormancy. Promoters from PtM3 or PtM4 may also be
useful in developing sterile trees through selective inhibition
of plant reproductive meristems. Since, expression of PtM3
and PtM4 may be controlled by a tissue and temporal
specific promoter, constructing DNA constructs or expres
sion cassettes with the PtM3 promoter may allow for repro

EXAMPLE 4
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Expression of the antisense transgene was assessed in
immature plants by extraction of mRNA and Northern
blotting using the PTD cDNA as a probe, or by RT-PCR.
Flower specific mRNA expression patterns of PtM3 and
PtM4 were determined by using sequence specific primers
followed by RT-PCR of mRNA from various developmental
stages of aspen male and female flowers. RT-PCR products
were then blotted and probed with specific DNA probes for
PtM3 and PtM4. These experiments illustrated that both
PtM3 and PtM4 were expressed from early stages of devel
opment and the expression of these genes varied in sexes.
In order to obtain the Northern blot shown in FIG. 6, total
RNA (10 pg) from each developmental stage of female
aspen flowers was fractionated on a 1.2% formaldehyde
agarose gel and transferred to Flybond™ N-nylon mem
branes (purchased from Amersham). The Northern blot
membrane was hybridized to 32P-labeled probe at 68° C. and
washed at high stringency. The specific 3'UTR of PtM3 was
used as probe. Panel A shows expression of PtM3 mRNA at
specific flower bud developmental stages, as compared to
control tissues (leaf and xylem RNA). Panel B shows
expression of PtM4 mRNA at specific flower bud develop
mental stages, as compared to control tissues (leaf and
xylem RNA). Panel C shows the differential expression of
male PtM3 (M) and female (F) PtM4 floral buds from stage
4 as compared to leaf (L) and xylem (X) RNA. Panel D
shows the result of having the 3'-UTR probe of PtM3 used
to hybridize against total RNA from Stage 4 male and female
buds. Based on expression patterns of PtM3 and PtM4, it
appears that these genes are involved in the early stages of
flower development. PtM3 and PtM4 have great potential to
alter reproductive capacity of trees both to increase flower
ing time, and flower numbers and also to develop sterility.
Also, levels of PtM3 and PtM4 protein were analyzed by
extraction, purification and concentration of cellular proteins
to perform in situ hybridization or to make antibodies for
performing western or blots.
EXAMPLE 5
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Phenotypic Alterations in Plants Resulting from
Over-Expression of PtM3
The altered phenotypes of the transgenic plants over
expressing PtM3 were analyzed in the panels A-E of FIG.
7. Panel A, shows tobacco from transgenic line PtM3-21
(right) showing early flowering as compared to WT tobacco
(left). This early flowering is a potentially useful trait for
increased yield by allowing an increase in the number of
crops per growing season. Additionally, early flowering
could provide for the production of crops in conditions
which would not normally generate satisfactory yield to a
short growing season. Panel B, shows a T1 generation plant
from one control construct line pTCS5. Panel C, shows a T1
generation plant from transgenic line PtM3-9-9. Panel D,
shows a T3 generation transgenic Arabidopsis from line
PtM3-4-3 (right) displaying increased branching and flower
pod production as compared to WT (left). Panel E, shows a
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graph depicting the average seed yields (mg) and pod
numbers in the transgenic PtM3-4-3 plants (right) as com
pared to WT (left).
The present invention is applicable to many hardwood
tree species to control flowering including, Populus species,
cottonwoods, Sweetgum, eucalyptus, fruit trees such as
apple, peach, nut trees such as walnuts, pecans and almonds.
Since ectopic over expression of PtM3 in herbaceous plants
such as Arabidopsis and tobacco caused reduced juvenile
periods resulting in accelerated and earlier flowering and
increased fruit production (FIG. 7), it is likely that PtM3 and
PtM4 can be used for crop plants also to increase seed
output. Earlier flowering will allow for more rapid selective
breeding programs for economically important trees.
Increased branching and flower production will be useful for
increasing yields of fruit and nut trees and increase flower
yields for ornamentals. Further experiments have been con
ducted where the gene constructs containing Aspen PtM3
have been introduced into Aspen trees to develop over
expression in transgenic aspen where the juvenile period is
reduced and flowering is accelerated.

either to completely abolish flowering (sterility) or to reduce
juvenile periods and to accelerate flowering so that these
aspen plants can be used for breeding purposes within 2
years instead of the normal 6 to 8 years time period. Sterility
through either using the PtM3 gene promoter controlling a
cytotoxic RNAse gene or through using constructs with
antisense or inverted repeat sequences of PtM3 cDNA may
be very valuable for commercialization of genetically modi
fied trees. Once the trees are sterilized additional genes with
other useful traits in the forest products industry such as
wood quality, rapid growth or pest and herbicide resistance
can be introduced into the sterile tree. Also, since, trees like
aspen can be vegetatively propagated, once a transgenic line
with chosen phenotype is obtained it can be scaled up. The
methods for generating transgenic aspen are available and
are developed in our lab (Boerjan et ah, 1997; Kamosky et
al, 2000; Kim, J. H. 1998; Tsai et al, 1994; 1998).
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Other Applications Using the Disclosed Sequences

EXAMPLE 6
Phenotypic Alterations in Plants Resulting from
Suppressed Expression of PtM3
FIG. 8, Panels A-H illustrates the altered phenotypes of
the transgenic plants with suppressed PtM3 expression.
Panels A and B show a control plant and a plant with an
antisense PtM3 incorporated into a plant, respectively. In
panel A the control is flowering. In panel B, the antisense
PtM3 tobacco plant is not flowering. In fact the antisense
PtM3 containing plants mature, begin senescing and even
tually die without flowering. Panel C shows a transgenic
tobacco plant containing inverted repeats of a portion of the
PtM3 sequence which does not form flowers, in comparison
to the control plants that form normal flowers (panel D).
Panels E and F show the absence of petals and stamens when
an inverted repeat of male PtM3 is introduced into the
bisexual tobacco plant. Only female sex organ is formed and
can be pollinated by pollen from a control to form pods.
These results show that the PtM3 may also have a role in the
male sex determination. Panel G shows flowerless Arabi
dopsis terminal and Panel H shows normal pod development
in control.
Antisense or inverted repeat constructs of PtM3 were used
to suppress gene expression resulting in complete sterility or
sterility of one of the sex organs in tobacco and Arabidopsis.
Generating sterile trees for commercial fiber farming of trees
with value added genes to meet the regulations by USDA,
EPA, etc. Selective inhibition of either female or male
organs will have significant use in breeding programs for
various tree and perennial species. Also, reduced promoter
activity from PtM3 will be useful in developing sterile trees
by selective inhibition of reproductive meristems. Also, the
inhibition of flowering using a PtM3-RNAse cassette or any
other cytotoxic gene, may have an added benefit by pre
venting reproductive development at the earliest stage. The
methods of the present invention result in an advantageous
energy savings which allows the plant to increase the
biomass through increased branching because the growing
conditions are not limiting.
Since aspen is a dioecious tree (sexes are on different
trees), PtM3 and PtM4 could also be used to control either
male or female reproductive structures and will be useful for
breeding. For example, transgenic aspen can be generated
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The disclosed floral reproductive genes and polypeptides
may be useful as laboratory reagents to study and analyze
floral gene expression in plants, including plants engineered
for modified fertility characteristics. For example, probes
and primers derived from the PtM3 sequence, as well as
monoclonal antibodies specific for the PtM3 polypeptide
may be used to detect and quantify expression of PtM3 in
seedlings transformed with an antisense PtM3 construct as
described above. Such analyses would facilitate detection of
those transformants that display modified PtM3 expression
and which may therefore be good candidates for having
modified fertility characteristics.
The production of probes and primers derived from the
disclosed sequences is described in detail above. Production
of monoclonal antibodies requires that all or part of the
protein against which the antibodies to be raised be purified.
With the provision herein of the floral reproductive gene
sequences, as well as the sequences of the encoded polypep
tides, this may be achieved by expression in heterologous
expression systems, or chemical synthesis of peptide frag
ments.
Many different expression systems are available for
expressing cloned nucleic acid molecules. Examples of
prokaryotic and eukaryotic expression systems that are
routinely used in laboratories are described in Sambrook et
al. supra at Ch. 16-17. Such systems maybe used to express
the floral reproductive polypeptides at high levels to facili
tate purification.
By way of example only, high level expression of a floral
reproductive polypeptide may be achieved by cloning and
expressing the selected cDNA in yeast cells using the
pYES2 yeast expression vector (Invitrogen, San Diego,
Calif.). Secretion of the recombinant floral homeotic
polypeptide from the yeast cells may be achieved by placing
a yeast signal sequence adjacent to the floral reproductive
gene coding region. A number of yeast signal sequences
have been characterized, including the signal sequence for
yeast invertase. This sequence has been successfully used to
direct the secretion of heterologous proteins from yeast cells,
including such proteins as human interferon (Chang et al.
(1986). Saccharomyces cerevisiae secretes and correctly
processes human interferon hybrid protein containing yeast
invertase signal peptides. Mol. and Cell. Biol.
6:1812-1819.) and human lactoferrin (Liang and Richard
son (1993). Expression and characterization of human lacto-
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ferrin in yeast (Saccharomyces cerevisiae). J. Agric. Food
Peptides as short as 3 or 4 amino acids in length may be
Chem. 41:1800-1807). Alternatively, the enzyme may be
immunogenic when presented to the immune system in the
expressed at high level in prokaryotic expression systems,
context of a Major Histocompatibility Complex (MHC)
such as in E. coli.
molecule, such as MHC class I or MHC class II. Accord
Monoclonal or polyclonal antibodies may be produced to 5 ingly, peptides comprising at least 3 and suitably at least 4,
the selected floral reproductive polypeptide, functionally
5, 6 or 10 or more consecutive amino acids of the disclosed
equivalent fragments thereof or portions thereof. Optimally,
floral reproductive polypeptide amino acid sequences may
antibodies raised against a specified floral reproductive
be employed as immunogens to raise antibodies. Because
polypeptide will specifically detect that polypeptide. That is,
naturally occurring epitopes on proteins are frequently com
for example, antibodies raised against the PtM3 polypeptide to
prised of amino acid residues that are not adjacently
would recognize and bind the PtM3 polypeptide and would
arranged in the peptide when the peptide sequence is viewed
not substantially recognize or bind to other proteins found in
as a linear molecule, it may be advantageous to utilize longer
poplar cells. The determination that an antibody specifically
peptide
fragments from the floral reproductive polypeptide
detects PtM3 is made by any one of a number of standard
immunoassay methods; for instance, the Western blotting 15 amino acid sequences in order to raise antibodies. Thus, for
example, peptides that comprise at least 10, 15, 20, 25 or 30
technique (Sambrook et al., 1989). To determine that a given
consecutive amino acid residues of the floral reproductive
antibody preparation (such as one produced in a mouse
polypeptide
amino acid sequence may be employed. Mono
against PtM3) specifically detects PtM3 by Western blotting,
clonal or polyclonal antibodies to the intact floral reproduc
total cellular protein is extracted from poplar cells and
electrophoresed on a sodium dodecyl sulfate-polyacryla- 20 tive polypeptide or peptide fragments of this protein may be
prepared as described below.
mide gel. The proteins are then transferred to a membrane
Monoclonal antibody to epitopes of the selected floral
(for example, nitrocellulose) by Western blotting, and the
reproductive polypeptide can be prepared from murine
antibody preparation is incubated with the membrane. After
hybridomas according to the classical method of Kohler and
washing the membrane to remove non-specifically bound
antibodies, the presence of specifically bound antibodies is 25 Milstein (1975) or derivative methods thereof. Briefly, a
mouse is repetitively inoculated with a few micrograms of
detected by the use of an anti-mouse antibody conjugated to
the selected protein over a period of a few weeks. The mouse
an enzyme such as alkaline phosphatase; application of the
is then sacrificed, and the antibody-producing cells of the
substrate 5-bromo-4-chloro-3-indolyl phosphate/nitro blue
spleen isolated. The spleen cells are fused by means of
tetrazolium results in the production of a dense blue com
pound by immuno-localized alkaline phosphatase. Antibod- 30 polyethylene glycol with mouse myeloma cells, and the
excess unfused cells destroyed by growth of the system on
ies which specifically detect PtM3 will, by this technique, be
selective media comprising aminopterin (HAT media). The
shown to bind to substantially only the PTD band (which
successfully fused cells are diluted and aliquots of the
will be localized at a given position on the gel determined by
dilution placed in wells of a microtiter plate where growth
its molecular weight). Non-specific binding of the antibody
to other proteins may occur and may be detectable as a weak 35 of the culture is continued. Antibody-producing clones may
be identified by detection of antibody in the supernatant fluid
signal on the Western blot. The non-specific nature of this
of the wells by immunoassay procedures, such as ELISA, as
binding will be recognized by one skilled in the art by the
originally described by Engvall (1980); and derivative meth
weak signal obtained on the Western blot relative to the
ods thereof. Selected positive clones can be expanded and
strong primary signal arising from the specific antibodyPtM3 binding.
40 their monoclonal antibody product harvested for use.
Detailed procedures for monoclonal antibody production are
Substantially pure floral reproductive polypeptides suit
described in Harlow and Lane (1988). Antibodies: A Labo
able for use as an immunogen may be isolated from trans
ratory Manual, Cold Spring Harbor Laboratory, New York.
formed cells as described above. Concentration of protein in
the final preparation is adjusted, for example, by concentra
Having illustrated and described the principles of isolat
tion on an Amicon filter device, to the level of a few 45 ing the full-length floral reproductive genes, methods and
micrograms per milliliter. Alternatively, peptide fragments
kits for expressing the proteins encoded by these genes to
of the specified floral reproductive polypeptide may be
obtain a variety of desired phenotypes, it should be apparent
utilized as immunogens. Such fragments may be chemically
to one skilled in the art that the invention can be modified in
synthesized using standard methods, or may be obtained by
arrangement and detail without departing from such prin
cleavage of the whole floral reproductive polypeptide fol- 50 ciples. We claim all modifications coming within the spirit
lowed by purification of the desired peptide fragments.
and scope of the claims presented herein.

SEQUENCE LISTIN G

<160> NUMBER OF SEQ ID NOS: 11
< 2 10>
< 2 1 1>
< 2 12>
< 2 13>

SEQ ID NO 1
LENGTH: 930
TYPE: DNA
ORGANISM: A sp e n

<400> SEQUENCE: 1
a g aag acaac c g a a g c a c tt c t t t a a a c t t a t a a c t t t c t c t t t c t a c a a

a c a tttg ttg

60
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-continued
ttctctctat tattgttaag gaatatgggg agaggtagag tggagotgaa gaggatagag

120

aacaagataa acaggcaggt gacatttgca aagaggagaa atgggttgtt gaagaaagct

180

tatgagttat ctgtgctctg tgatgctgag gttgctctca tcatcttctc taaccgtggc

240

aagctctacg agttttgtag cacatctaac atgctgaaga ccctggaaag gtatcagaag

300

tgcagctatg gtgcagaaga agtcaataaa ccagccaagg agctcgagaa cagctacagg

360

gagtacttga aagtgaaagc aagatttgag ggcctacaac gaactcagag gaaccttctt

420

ggagaggacc tcggacctct gaataccaaa gaccttgagc agctcgagcg t cagttagag

480

tcgtcattga accaagttcg gtcaactaag acccagtata tgctcgacca acttgctgat

540

cttcaaaata aggaacatct gttgcaggaa gctaacagag gtttgacaat aaagctggat

600

gaaatcagtg caagaaatag cctccgacca tcatgggaag gtgatgatca gcaaaatatg

660

tcctacggcc accagcatgc tcagtctcag gggctattcc aggctttgga atgcaatccc

720

actttgcaaa taggctacaa ccctgttggt tcagaccagg tgtctgcaat aacacatgcc

780

acccagcaag tccatgggtt cattccagga tggatgcttt gagttttgtg ctcttcattg

840

ctcataaagg agcacctacc atgtaacttt ctctcttggt gttggtaatg t gtaaatgat

900

ttcaagagca tgtgtacttt catttggaca

930

< 2 10>
< 2 1 1>
< 2 12>
< 2 13>
<220>
<221>
<223>

SEQ ID NO 2
LENGTH: 914
TYPE: DNA
ORGANISM: Aspen
FEATURE:
NAME/KEY: misc_feature
OTHER INFORMATION: n = a or• g or c or t/u

<400> SEQUENCE: 2
gtgtggtata tggggagagg tagagtggag ctgaagagga tagaaaacaa aattaatcgg

60

caggtgacat ttgcaaagag gagaaatggg ttgttgaaga aagcttatga gttatctgtg

120

ctctgtgatg ctgaggttgc tctcatcatc ttctctaacc gtggcaagct ctacgagttt

180

tgtagcacat ctaacatgct gaagaccctg gaaaggtatc agaagtgcag ctatggtgca

240

gaagaagtca ataaaccagc caaggagctc gagaacagct acagggagta cttgaaagtg

300

aaagcaagat ttgaggccct acaacgaact cagaggaacc ttcttggaga ggacctcgga

360

cctctgaata ccaaagatct tgagcagctc gagcgtcagt tagagtcgtc attgaaccaa

420

gttcggtcaa ctaagaccca gtatatgctc gaccaacttg ctgatcttca aaataaggaa

480

catctgttgc tggaagctaa cagaggtttg acaataaagc tggatgaaat cagtgcaaga

540

aatagcctcc gaccatcatg ggaaggtgat gatcagcaaa atatgtccta cggncaccag

600

cacgctcagt ctcaggggct attccaggct ttggaatgca atcccacttt gcaaataggc

660

tacaacgctg ttggttcaga ccaggtgtct gcaataacac atgccaccca gcaagtccat

720

gggttcattc caggatggat gctttgagtt ttgtgttctt cattgctcat aaaggagcac

780

ctaccatgta actttctctc ttggtgttgg taatgtgtaa atgatttcaa gagcatgtgt

840

actttcattt ggacatgaaa actttatgtg gctggatttc agaactttag ccagggacac

900

gaggcatgta aaag

914

< 2 10>
< 2 1 1>
< 2 12>
< 2 13>

SEQ ID NO 3
LENGTH: 1477
TYPE: DNA
ORGANISM: Aspen
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-continued

<400> SEQUENCE:

3

ggcccggctg gttctcatgt tggactccga ctttaattac tttaactaca agcttattat

60

aatttttttt ttatactatt ttatttcatt tcagtattta aacattattg t ttatataaa

120

aaaatagttg agcccgtggc aaagcataaa ccaagaccga atattctaaa t actaaattt

180

ctagtttgtt tgatttctca atgccccgaa cagtaacgct gtaatcagac aacctcatcc

240

ggacaagcca aatcaagaac tttctccagt atcaaaccga cacgtggagg agctccattt

300

taagggaggg gactactttc tgccacgtgt ggaaacatct ggaaatgaca aattgatgcc

360

atataaaatt ttcttacatg aaaggaccac tgtccctttt tacgccccac cgcagcgcgt

420

gaccacactt acaaccctac ctccaacaac actgacacaa tgaccgagac ggtggogogt

480

gaatacactc tccaaactta gaacctacgt tcgtaatcaa tgatgtgaca aaaaagtaaa

540

aaccaagaag ctttgaaagc taataaatga attactatat atattatatc aattcttcaa

600

gaaaattgga agaaattatt ttttttcaat ttaatttata aatataacta t ttaatgggg

660

aaagacttct atcctttgga accttaattg gaaaagcagc aaccccatgc cgttaacttg

720

aaaaaaaacg aaacccgggt gtattaaaaa cttaccaaca agggggtaao cttccactaa

780

ccgtgtacaa tggcaaagta acccaactta aggaaaaaga ttccataaat aaaaccattt

840

tcaaaatgta aaatattttt tcaaatattt ataaataact atattaatgt gaaagccatc

900

ataatcccga ttaggagata cttaattagg agaaagtcaa gtcgagaacc cccattgccg

960

ttaatacttg aaaaataaac cagtaaaata cacagaggtt gcatgtaact agaaagaaca

1020

gctaacccta agctgcattt cttttctata tatatatata tatataacag aaaagaagaa

1080

gacaaccgaa gcacttcttt aaacttataa ctttctcttt ctacaaacat t tgttgttct

1140

ctctattatt ggtgggtott tctttctctc tagggtttot ttaaaatatc taactttctc

1200

ttcgtttttc acttattttg ttacagtttg ggttctgatt cctaaaagtg t agatcacct

1260

tcttcttgct cttgagagaa gaacaagaaa cgaaaaaaaa aacaaaagaa aaggaaagat

1320

ataaaggaaa taaagactaa tacaaaagta aatatatcat taacttacat ggttagattt

1380

atgtattaat tataacgaaa gatggttttt tatttggttt tttttggctt gtgattatag

1440

ttaaggaata tggggagagg tagagtggag ctgaaga

1477

< 2 10>
< 2 1 1>
< 2 12>
< 2 13>

SEQ ID NO 4
LENGTH: 245
TYPE: PRT
ORGANISM: Aspen

<400> SEQUENCE:

4

Met Gly Arg Gly Arg Val Glu Leu Lys Arg lie Glu A sn Lys lie Asn
1
5
10
15
Arg Gin Val Thr Phe Ala Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala
20
25
30
Tyr Glu Leu Ser Val Leu Cys Asp Ala Glu Val A la Leu lie lie Phe
35
40
45
Ser Asn Arg Gly Lys Leu Tyr Glu Phe Cys Ser Thr Ser A sn M et Leu
50
55
60
Lys Thr Leu Glu Arg Tyr Gin Lys Cys Ser Tyr Gly A la Glu Glu Val
65
70
75
80
Asn Lys Pro Ala Lys Glu Leu Glu Asn Ser Tyr A rg Glu Tyr Leu Lys
85
90
95
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48
-continued

Val Lys Ala Arg Phe Glu Gly Leu Gin Arg Thr Gin Arg Asn Leu Leu
100
105
110
Gly Glu Asp Leu Gly Pro Leu Asn Thr Lys Asp Leu Glu Gin Leu Glu
115
120
125
Arg Gin Leu Glu Ser Ser Leu Asn Gin Val Arg Ser Thr Lys Thr Gin
130
135
140
Tyr Met Leu Asp Gin Leu Ala Asp Leu Gin Asn Lys Glu His Leu Leu
145
150
155
160
Gin Glu Ala Asn Arg Gly Leu Thr lie Lys Leu Asp Glu lie Ser Ala
165
170
175
Arg Asn Ser Leu Arg Pro Ser Trp Glu Gly Asp Asp Gin Gin Asn Met
180
185
190
Ser Tyr Gly His Gin His Ala Gin Ser Gin Gly Leu Phe Gin Ala Leu
195
200
205
Glu Cys Asn Pro Thr Leu Gin lie Gly Tyr Asn Pro Val Gly Ser Asp
210
215
220
Gin Val Ser Ala lie Thr His Ala Thr Gin Gin Val His Gly Phe lie
225
230
235
240
Pro Gly Trp Met Leu
245

< 2 10>
< 2 1 1>
< 2 12>
< 2 13>

SEQ ID NO 5
LENGTH: 245
TYPE: PRT
ORGANISM: Aspen

<400> SEQUENCE: 5
Met Gly Arg Gly Arg Val Glu Leu Lys Arg lie Glu Asn Lys lie Asn
1
5
10
15
Arg Gin Val Thr Phe Ala Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala
20
25
30
Tyr Glu Leu Ser Val Leu Cys Asp Ala Glu Val Ala Leu lie lie Phe
35
40
45
Ser Asn Arg Gly Lys Leu Tyr Glu Phe Cys Ser Thr Ser Asn Met Leu
50
55
60
Lys Thr Leu Glu Arg Tyr Gin Lys Cys Ser Tyr Gly Ala Glu Glu Val
65
70
75
80
Asn Lys Pro Ala Lys Glu Leu Glu Asn Ser Tyr Arg Glu Tyr Leu Lys
85
90
95
Val Lys Ala Arg Phe Glu Ala Leu Gin Arg Thr Gin Arg Asn Leu Leu
100
105
110
Gly Glu Asp Leu Gly Pro Leu Asn Thr Lys Asp Leu Glu Gin Leu Glu
115
120
125
Arg Gin Leu Glu Ser Ser Leu Asn Gin Val Arg Ser Thr Lys Thr Gin
130
135
140
Tyr Met Leu Asp Gin Leu Ala Asp Leu Gin Asn Lys Glu His Leu Leu
145
150
155
160
Leu Glu Ala Asn Arg Gly Leu Thr lie Lys Leu Asp Glu lie Ser Ala
165
170
175
Arg Asn Ser Leu Arg Pro Ser Trp Glu Gly Asp Asp Gin Gin Asn Met
180
185
190
Ser Tyr Gly His Gin His Ala Gin Ser Gin Gly Leu Phe Gin Ala Leu
195
200
205
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50
-continued

Glu Cys Asn Pro Thr Leu Gin lie Gly Tyr Asn A la Val Gly Ser Asp
210
215
220
Gin Val Ser Ala lie Thr His Ala Thr Gin Gin Val His Gly Phe lie
225
230
235
240
Pro Gly Trp Met Leu
245

< 2 10>
< 2 1 1>
< 2 12>
< 2 13>

SEQ ID NO 6
LENGTH: 29
TYPE: DNA
ORGANISM: Aspen

<400> SEQUENCE:

6

gttaaggaat atggggagag gtagagtgg

< 2 10>
< 2 1 1>
< 2 12>
< 2 13>

29

SEQ ID NO 7
LENGTH: 31
TYPE: DNA
ORGANISM: Aspen

<400> SEQUENCE:

7

gtccctggct aaagttctga aatccagcca c

< 2 10>
< 2 1 1>
< 2 12>
< 2 13>

31

SEQ ID NO 8
LENGTH: 29
TYPE: DNA
ORGANISM: Aspen

<400> SEQUENCE:

8

gatagagaac aagataaaca ggcaggtga

< 2 10>
< 2 1 1>
< 2 12>
< 2 13>

29

SEQ ID NO 9
LENGTH: 24
TYPE: DNA
ORGANISM: Aspen

<400> SEQUENCE:

9

gttcctctga gttcgttgta gggc

< 2 10>
< 2 1 1>
< 2 12>
< 2 13>

24

SEQ ID NO 10
LENGTH: 23
TYPE: DNA
ORGANISM: Aspen

<400> SEQUENCE:

10

caagatttga ggccctacaa cga

< 2 10>
< 2 1 1>
< 2 12>
< 2 13>

23

SEQ ID NO 11
LENGTH: 31
TYPE: DNA
ORGANISM: Aspen

<400> SEQUENCE:

11

gtccctggct aaagttctga aatccagcca c

31

60

What is claimed is:
1. An isolated polynucleotide encoding a polypeptide,
wherein the polypeptide comprises SEQ ID NO:4.
2. An isolated polynucleotide comprising the coding
sequence of SEQ ID NO:l, the complement of the coding
sequence of SEQ ID. NO:l, the reverse complement of the

65

coding sequence of SEQ ID. NO:l, the full-length reverse
sequence of the coding sequence of SEQ ID. NO:l, or a
combination thereof.
3. An isolated polynucleotide comprising:
(a) SEQ ID NO:l
(b) the full-length complement of SEQ ID NO: 1
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(c) the reverse full-length complement of SEQ ID NO: 1
or
(d) the reverse full-length sequence of SEQ ID NO:l.
4. An isolated polynucleotide encoding a polypeptide
having at least 97% amino acid sequence identity to SEQ ID
NO:4.
5. A construct comprising:
a polynucleotide encoding a polypeptide, wherein the
polypeptide comprises an amino acid sequence having
at least 97% identity to SEQ ID NO:4, said polynucle
otide operably linked to a promoter.
6. An isolated host cell transformed with the construct as
set forth in claim 5.
7. A transgenic plant comprising at least one construct of
claim 5.
8. A transgenic tree comprising at least one construct of
claim 5.
9. A construct as set forth in claim 5, wherein the construct
further comprises a promoter selected from the group con
sisting of a constitutive promoter, a tissue-specific promoter,
a temporal-specific promoter, a developmentally regulated
promoter, and a combination thereof.
10. A method of altering a characteristic of a plant,
comprising transforming the plant with the construct as set
forth in claim 5, wherein the altered characteristic is selected
from the group consisting of accelerated flowering time,
increased flowering number, increased fruit production,
increased nut production, increased seed output, increased
branching, conversion of axillary meristems to floral meristems, increased reproductive capacity of sex organs, early
reproductive development, and combinations thereof com
pared to a control plant that is not transformed with the
construct.
11. The method as set forth in claim 10, wherein the plant
exhibits increased biomass.
12. A method of producing a transgenic plant having at
least one altered characteristic compared to a nontransgenic
control plant, wherein the method comprises:
(a) introducing into a plant cell a polynucleotide encoding
a polypeptide comprising SEQ ID NO:4, to yield a
transformed cell; and
(b) generating the transgenic plant from the transformed
cell, the plant having at least one altered characteristic
selected from the group consisting of (i) axillary meristem converted to floral meristem; (ii) accelerated
flowering; (iii) early reproductive development; (iv)
increased fruit production; (v) earlier flowering times;
(vi) increased seed output; (vii) increased branching;
(viii) increased flower production; (ix) increased fruit
yield; and (x) increased flower yields.
13. The method as set forth in claim 12, wherein the plant
is selected from the group consisting of a herbaceous plant,
a crop plant, a perennial plant, a hybrid plant, a seed plant,
a flowering plant, a tobacco plant, and an Arabidopsis plant.
14. The method as set forth in claim 12, wherein the plant
is a tree.
15. The method as set forth in claim 14, wherein the tree
includes at least one of a dioecious tree, a hybrid tree, a
bisexual tree, a hardwood tree, or a Populus tree.

16. The method as set forth in claim 14, wherein the tree
is Aspen.
17. The method of altering the reproductive capacity of a
plant comprising:
(a) stably transforming a plant cell with the construct of
claim 5, wherein the polynucleotide is incorporated in
the genome of the plant cell; and
(b) growing the plant cell to produce a regenerated plant
capable of expressing a polypeptide encoded by the
polynucleotide for a time sufficient to alter the repro
ductive capacity of the plant.
18. The method as set forth in claim 17, wherein the
polypeptide is over-expressed.
19. A method of ectopically expressing a polypeptide
encoded by a floral reproductive gene in a plant, comprising
introducing into the genome of the plant the construct of
claim 5.
20. A method of producing a transgenic plant having
altered reproductive capacity compared to a nontransgenic
control plant, the method comprising:
(a) introducing into a plant cell a polynucleotide encoding
a polypeptide comprising SEQ ID NO:4 to yield a
transformed cell;
(b) generating a transgenic plant from the transformed
cell, wherein the plant has altered reproductive capac
ity.
21. The method as set forth in claim 20, wherein the plant
is selected from the group consisting of a herbaceous plant,
a crop plant, a perennial plant, a hybrid plant, a seed plant,
a flowering plant, a tobacco plant, and an Arabidopsis plant.
22. The method as set forth in claim 20, wherein the plant
is a tree.
23. The method as set forth in claim 22, wherein the tree
is selected from the group consisting of a dioecious tree, a
hybrid tree, a bisexual tree, a hardwood tree, and a Populus
tree.
24. The method as set forth in claim 22, wherein the tree
is Aspen.
25. The method as set forth in claim 20, further compris
ing introducing an additional exogenous nucleotide
sequence into the genome of the plant, wherein a polypep
tide encoded by the additional exogenous nucleotide
sequence is expressed in the plant, such that the plant
exhibits increased herbicide resistance.
26. The method as set forth in claim 20, wherein the
altered plant characteristic is selected front the group con
sisting of increased plant biomass, reduced pollen produc
tion and combinations thereof.
27. A plant produced by the method of claim 12.
28. A plant produced by the method of claim 17.
29. A plant produced by the method of claim 19.
30. A plant produced by the method of claim 20.
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